Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.


Funktionen

  • Mitglied/er, Innere Klinik (Tumorforschung)

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Guberina, Maja; Pöttgen, Christoph; Guberina, Nika; Hoffmann, Christian; Wiesweg, Marcel; Richlitzki, Cedric; Metzenmacher, Martin; Aigner, Clemens; Bölükbas, Servet; Gauler, Thomas; Eberhardt, Wilfried; Forsting, Michael; Herrmann, Ken; Theegarten, Dirk; Darwiche, Kaid; Jendrossek, Verena; Stuschke, Martin; Schuler, Martin
    Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment : Comparison with Stage III Disease
    In: Cancers Jg. 16 (2024) Nr. 6, 1174
  • Sebastian, Martin; Eberhardt, Wilfried E. E.; von der Heyde, Eyck; Dörfel, Steffen; Wiegand, Jörg; Schiefer, Clemens; Losem, Christoph; Jänicke, Martina; Fleitz, Annette; Zacharias, Stefan; Kaiser-Osterhues, Anja; Hipper, Annette; Dietel, Corinna; Bleckmann, Annalen; Benkelmann, Robin; Boesche, Michael; Grah, Christian; Müller, Annette; Griesinger, Frank; Thomas, Michael
    Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic : Real-world data from the German prospective CRISP Registry (AIO-TRK-0315)
    In: International Journal of Cancer (2024) in press
  • Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Oezkan, Filiz; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Hamacher, Rainer; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, Hubertus
    68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients : A Single-Center Retrospective Study
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 10, S. 1540 - 1549
  • Hockmann, Jan; Hautzel, Hubertus; Darwiche, Kaid; Eberhardt, Wilfried; Stuschke, Martin; Aigner, Clemens; Herrmann, Ken; Plönes, Till
    Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancer
    In: Asian Cardiovascular and Thoracic Annals Jg. 31 (2023) Nr. 6, S. 506 - 511
  • Kraskowski, Oliver; Stratmann, Jan A.; Wiesweg, Marcel; Eberhardt, Wilfried; Metzenmacher, Martin; Schmid, Kurt Werner; Herold, Thomas; Schildhaus, Hans-Ulrich; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Laue, Katharina; Zaun, Gregor; Kasper, Stefan; Hense, Jörg; Sebastian, Martin; Schuler, Martin; Pogorzelski, Michael
    Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 11, S. 9243 - 9252
  • Griesinger, Frank; Hummel, Horst-Dieter; Schäfer, Harald; de Wit, Maike; Kaiser, Ulrich; Kern, Jens; Jänicke, Martina; Spring, Lisa; Zacharias, Stefan; Kaiser-Osterhues, Anja; Groth, Annika; Hipper, Annette; Zaun, Gregor; Müller, Lothar; Uhlig, Jens; Thomas, Michael; Sebastian, Martin; Eberhardt, Wilfried; Ababei, Juliana; Alt, Jürgen; Ammon, Andreas; Anhuf, Jürgen; Azeh, Ivo; Bauer, Stefan; Behringer, Dirk; Berger, Winfried; Bernhardt, Christiane; Bertram, Mathias; Boesche, Michael; Bohnet, Sabine; Bruch, Harald-Robert; Brückl, Wolfgang; Burkhard-Meier, Ulrike; Christopoulos, Petros; Däßler, Klaus-Ulrich; Dechow, Tobias; Depenbusch, Reinhard; Dietze, Lutz; Dommach, Markus; Dörfel, Steffen; Elender, Corinna; Elsel, Wolfgang; Emde, Till-Oliver; Faehling, Martin; Fietz, Thomas; Fischer, Jürgen R.; Flieger, Dimitri; Freidt, Anke; Freier, Werner; Frenzel, Christian; Fuchs, Florian; Fuchs, Roswitha; Gaska, Tobias; Gleiber, Wolfgang; Grah, Christian; Grohé, Christian; Groschek, Matthias; Güldenzoph, Björn; Günther, Andreas; Haas, Siegfried; Hackenthal, Matthias; Hagen, Volker; Hahn, Lars; Hannig, Carla Verena; Hansen, Richard; Harich, Hanns-Detlev; Heilmann, Monika; Heinrich, Kathrin; Hering-Schubert, Christiane; Heßling, Jörg; Hoffknecht, Petra; Hortig, Patricia; Hübner, Gerdt; Hutzschenreuter, Ulrich; Illmer, Thomas; Innig, Georg; Jaeschke, Bastian; Junghanß, Christian; Kamal, Haytham; Kambartel, Kato; Kimmich, Martin; Kingreen, Dorothea; Kirchen, Heinz; Klausmann, Martine; Klein, Ortwin; Kokowski, Konrad; Körber, Wolfgang; Kortsik, Cornelius; Koschel, Dirk; Krämer, Benoit; Krammer-Steiner, Beate; Laack, Eckart; Lamberti, Christof; Leistner, Rumo David; Losem, Christoph; Lück, Andreas; Maintz, Christoph; Martin, Kerstin; Medgenberg, Dirk; Metzenmacher, Martin; Meyer zum Büschenfelde, Christian; Meyn, Philipp; Moorahrend, Enno; Müller, Annette; Neise, Michael; Nückel, Holger; Nusch, Arnd; Overbeck, Tobias; Pelz, Henning; Petersen, Volker; Peuser, Bettina; Plath, Margarete; Randerath, Winfried J.; Rauh, Jacqueline; Reck, Martin; Reichert, Dietmar; Reinmuth, Niels; Reiser, Marcel; Repp, Roland; Reschke, Daniel; Rittmeyer, Achim; Rodemer, Yolanda; Sackmann, Sandra; Sadjadian, Parvis; Sandner, Reiner; Sauer, Annette; Schaudt, Christoph; Schlag, Rudolf; Schmidt, Burkhard; Schmitz, Stephan; Schröder, Jan; Schroeder, Michael; Schulze, Mathias; Schumann, Christian; Schütte, Wolfgang; Schwaiblmair, Martin; Schwindt, Peter Florian; Seese, Bernd; Seipelt, Gernot; Sorgenfrei, Thomas; Steiff, Johannes; Steiniger, Heike; Trarbach, Tanja; Tufman, Amanda; Vehling-Kaiser, Ursula; von der Heyde, Eyck; von Verschuer, Ulla; Waller, Cornelius; Wehler, Thomas; Weißenborn, Georg; Weißinger, Florian; Wermke, Martin; Wesseler, Claas; Wiegand, Jörg; Wilhelm, Stefan; Wilke, Jochen; Zahn, Mark-Oliver; Zaiss, Matthias; Zeth, Matthias
    Prognostic factors in nonsmall cell lung cancer : insights from the German CRISP registry
    In: European Respiratory Journal (ERJ) Jg. 61 (2023) Nr. 2, 2201336
  • Zaun, Gregor; Weber, Manuel; Metzenmacher, Martin; Wiesweg, Marcel; Hilser, Thomas; Zaun, Yasmin; Liffers, Sven; Pogorzelski, Michael; Virchow, Isabel; Eberhardt, Wilfried; Theurer, Sarah; Sabbah, Tanja Abu; Reissig, Timm M.; Stuschke, Martin; Kürten, Cornelius; Hussain, Timon; Lang, Stephan; Kasper, Stefan; Fendler, Wolfgang; Herrmann, Ken; Schuler, Martin
    SUVmₐₓ Above 20 in ¹⁸F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 8, S. 1191 - 1194
  • Guberina, Maja; Guberina, Nika; Pöttgen, Christoph; Gauler, Thomas; Richlitzki, Cedric; Metzenmacher, Martin; Wiesweg, Marcel; Plönes, Till; Forsting, Michael; Wetter, Axel; Herrmann, Ken; Hautzel, Hubertus; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Stuschke, Martin; Eberhardt, Wilfried
    Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer : focus on treatment selection and prognostic factors
    In: Immunotherapy Jg. 14 (2022) Nr. 12, S. 927 - 944
  • Pfannschmidt, Joachim; Guckenberger, M.; Eberhardt, Wilfried
    Konzepte beim oligometastasierten Lungenkarzinom
    In: Die Onkologie Jg. 28 (2022) Nr. 12, S. 1078 - 1086
  • Guberina, Nika; Pöttgen, Christoph; Schuler, Martin; Guberina, Maja; Stamatis, Georgios; Plönes, Till; Metzenmacher, Martin; Theegarten, Dirk; Gauler, Thomas; Darwiche, Kaid; Aigner, Clemens; Eberhardt, Wilfried; Stuschke, Martin
    Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment
    In: Radiation Oncology Jg. 17 (2022) Nr. 1, 126
  • Guberina, Maja; Herrmann, Ken; Pöttgen, Christoph; Guberina, Nika; Hautzel, Hubertus; Gauler, Thomas; Ploenes, Till; Umutlu, Lale; Wetter, Axel; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Metzenmacher, Martin; Wiesweg, Marcel; Schuler, Martin; Karpf-Wissel, Rüdiger; Santiago Garcia, Alina; Darwiche, Kaid; Stuschke, Martin
    Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT
    In: Scientific Reports Jg. 12 (2022) Nr. 1, 17511
  • Scheffler, Matthias; Wiesweg, Marcel; Michels, Sebastian; Nogová, Lucia; Kron, Anna; Herold, Thomas; Scheel, Andreas H.; Metzenmacher, Martin; Eberhardt, Wilfried; Reis, Henning; Fassunke, Jana; Darwiche, Kaid; Aigner, Clemens; Schaufler, Diana; Riedel, Richard; Fischer, Rieke; Koleczko, Sophia; Schildhaus, Hans-Ulrich; Merkelbach-Bruse, Sabine; Schmid, Kurt Werner; Büttner, Reinhard; Wolf, Jürgen; Schuler, Martin
    Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications
    In: Lung Cancer Jg. 168 (2022) S. 10 - 20
  • Stamatis, Georgios; Müller, Stefanie; Weinreich, Gerhard; Schwarz, Birte; Eberhardt, Wilfried; Pöttgen, Christoph; Aigner, Clemens
    Significantly favourable outcome for patients with non-small-cell lung cancer stage IIIA/IIIB and single-station persistent N2 (skip or additionally N1) disease after multimodality treatment
    In: European Journal of Cardio-Thoracic Surgery Jg. 61 (2022) Nr. 2, S. 269 - 276
  • Wiesweg, Marcel; Eberhardt, Wilfried; Schuler, Martin; Plönes, Till
    Therapie früher und lokal fortgeschrittener Stadien des nicht-kleinzelligen Lungenkarzinoms
    In: Die Innere Medizin Jg. 63 (2022) Nr. 7, S. 717 - 723
  • Metzenmacher, Martin; Kopp, Hans-Georg; Griesinger, Frank; Reinmuth, Niels; Sebastian, Martin; Serke, Monika; Waller, Cornelius Florian; Thomas, Michael; Eggert, Jochen; Schmid-Bindert, Gerald; Hoiczyk, Mathias; Christoph, Daniel; Kimmich, Martin; Deuß, Burkhard; Seifert, Stephanie; Held, Swantje; Schuler, Martin; Herold, Thomas; Breitenbücher, Frank; Eberhardt, Wilfried
    A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer
    In: Therapeutic Advances in Medical Oncology Jg. 13 (2021)
  • Metzenmacher, Martin; Goetz, Moritz; Herold, Thomas; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Eberhardt, Wilfried; Schuler, Martin; Wiesweg, Marcel
    Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V⁶⁰⁰-mutated Squamous Cell Lung Cancer : Concurrent Evolvement of PTEN and MEK1 Mutations
    In: Clinical Lung Cancer Jg. 22 (2021) Nr. 5, S. E668 - E672
  • Wiesweg, Marcel; Preuß, Cedric; Roeper, Julia; Metzenmacher, Martin; Eberhardt, Wilfried; Stropiep, Ursula; Wedeken, Katrin; Reis, Henning; Herold, Thomas; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Schildhaus, Hans-Ulrich; Schmid, Kurt Werner; Falk, Markus; Heukamp, Lukas; Tiemann, Markus; Griesinger, Frank; Schuler, Martin
    BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy
    In: European Journal of Cancer (EJC) Jg. 149 (2021) S. 211 - 221
  • Griesinger, Frank; Eberhardt, Wilfried; Nusch, Arnd; Reiser, Marcel; Zahn, Mark-Oliver; Maintz, Christoph; Bernhardt, Christiane; Losem, Christoph; Stenzinger, Albrecht; Heukamp, Lukas C.; Büttner, Reinhard; Marschner, Norbert; Jänicke, Martina; Fleitz, Annette; Spring, Lisa; Sahlmann, Jörg; Karatas, Aysun; Hipper, Annette; Weichert, Wilko; Heilmann, Monika; Sadjadian, Parvis; Gleiber, Wolfgang; Grah, Christian; Waller, Cornelius F.; Reck, Martin; Rittmeyer, Achim; Christopoulos, Petros; Sebastian, Martin; Thomas, Michael
    Biomarker testing in non-small cell lung cancer in routine care : Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)
    In: Lung Cancer Jg. 152 (2021) S. 174 - 184
  • Ferdinandus, Justin; Metzenmacher, Martin; Kessler, Lukas; Umutlu, Lale; Aigner, Clemens; Karl, Kambartel Otto; Grünwald, Viktor; Eberhardt, Wilfried; Fendler, Wolfgang Peter; Herrmann, Ken; Faehling, Martin; Christoph, Daniel
    Complete metabolic response in patients with advanced nonsmall cell lung cancer with prolonged response to immune checkpoint inhibitor therapy
    In: Journal for ImmunoTherapy of Cancer Jg. 9 (2021) Nr. 3, S. 002262
  • Griesinger, Frank; Eberhardt, Wilfried; Nusch, Arnd; Reiser, Marcel; Zahn, Mark-Oliver; Maintz, Christoph; Bernhardt, Christiane; Losem, Christoph; Stenzinger, Albrecht; Heukamp, Lukas C.; Büttner, Reinhard; Marschner, Norbert; Jänicke, Martina; Fleitz, Annette; Spring, Lisa; Sahlmann, Jörg; Karatas, Aysun; Hipper, Annette; Weichert, Wilko; Heilmann, Monika; Sadjadian, Parvis; Gleiber, Wolfgang; Grah, Christian; Waller, Cornelius F.; Reck, Martin; Rittmeyer, Achim; Christopoulos, Petros; Sebastian, Martin; Thomas, Michael
    Corrigendum to "Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315)" [Lung Cancer 152 (2021) 174-184
    In: Lung Cancer Jg. 157 (2021) S. 167
  • Schotten, Lea M.; Darwiche, Kaid; Seweryn, Michal; Yildiz, Vedat; Kneuertz, Peter J.; Eberhardt, Wilfried; Eisenmann, Stephan; Welter, Stefan; Sisson, Brianna E.; Pietrzak, Maciej; Wiesweg, Marcel; Plönes, Till; Hager, Thomas; He, Kai; Freitag, Lutz; Aigner, Clemens; Taube, Christian; Oezkan, Filiz
    DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients
    In: European Journal of Cancer (EJC) Jg. 147 (2021) S. 142 - 150
  • Aigner, Clemens; Brüning, T.; Eberhardt, Wilfried; Härter, M.; Kaelberlah, Hans-Peter; Metzenmacher, M.; Shah, R.; Taube, Christian; Thomas, M.
    Die aktuelle Therapie des asbestassoziierten malignen Pleuramesothelioms - Ein Experten-Konsensuspapier
    In: Pneumologie Jg. 75 (2021) Nr. 10, S. 776 - 794
  • Borghaei, Hossein; Gettinger, Scott; Vokes, Everett E.; Chow, Laura Q M; Burgio, Marco Angelo; de Castro Carpeno, Javier; Pluzanski, Adam; Arrieta, Oscar; Frontera, Osvaldo Arén; Chiari, Rita; Butts, Charles; Wójcik-Tomaszewska, Joanna; Coudert, Bruno; Garassino, Marina Chiara; Ready, Neal; Felip, Enriqueta; García, Miriam Alonso; Waterhouse, David; Domine, Manuel; Barlesi, Fabrice; Antonia, Scott; Wohlleber, Markus; Gerber, David E.; Czyzewicz, Grzegorz; Spigel, David R.; Crino, Lucio; Eberhardt, Wilfried; Li, Ang; Marimuthu, Sathiya; Brahmer, Julie
    Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 7, S. 723 - 733
  • Guberina, Maja; Darwiche, Kaid; Hautzel, Hubertus; Ploenes, Till; Pöttgen, Christoph; Guberina, Nika; Herrmann, Ken; Umutlu, Lale; Wetter, Axel; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Schuler, Martin; Karpf-Wissel, Rüdiger; Stuschke, Martin
    Impact of EBUS-TBNA in addition to [¹⁸F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) S. 2894 - 2903
  • Sebastian, Martin; Eberhardt, Wilfried; Hoffknecht, Petra; Metzenmacher, Martin; Wehler, Thomas; Kokowski, Konrad; Alt, Jürgen; Schütte, Wolfgang; Büttner, Reinhard; Heukamp, Lukas C.; Stenzinger, Albrecht; Jänicke, Martina; Fleitz, Annette; Zacharias, Stefan; Dille, Stephanie; Hipper, Annette; Sandberg, Marlen; Weichert, Wilko; Groschek, Matthias; von der Heyde, Eyck; Rauh, Jacqueline; Dechow, Tobias; Thomas, Michael; Griesinger, Frank
    KRAS G12C-mutated advanced non-small cell lung cancer : A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)
    In: Lung Cancer Jg. 154 (2021) S. 51 - 61
  • Hautzel, Hubertus; Alnajdawi, Yazan; Fendler, Wolfgang; Rischpler, Christoph; Darwiche, Kaid; Eberhardt, Wilfried; Umutlu, Lale; Theegarten, Dirk; Stuschke, Martin; Schuler, Martin; Aigner, Clemens; Herrmann, Ken; Plönes, Till
    N-staging in large cell neuroendocrine carcinoma of the lung : diagnostic value of [¹⁸F]FDG PET/CT compared to the histopathology reference standard
    In: EJNMMI Research Jg. 11 (2021) Nr. 1, 68
  • Harbeck, Nadia; Schneeweiss, Andreas; Thuss-Patience, Peter; Miller, Kurt; Garbe, Claus; Griesinger, Frank; Eberhardt, Wilfried; Klussmann, Jens P.; Wollenberg, Barbara; Grimm, Marc-Oliver; Zander, Thomas; Lüftner, Diana
    Neoadjuvant and adjuvant end-points in health technology assessment in oncology
    In: European Journal of Cancer (EJC) Jg. 147 (2021) S. 40 - 50
  • Guberina, Maja; Darwiche, Kaid; Hautzel, Hubertus; Pöttgen, Christoph; Guberina, Nika; Gauler, Thomas; Ploenes, Till; Umutlu, Lale; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Metzenmacher, Martin; Wiesweg, Marcel; Karpf-Wissel, Rüdiger; Schuler, Martin; Herrmann, Ken; Stuschke, Martin
    Patterns of nodal spread in stage III NSCLC : Importance of EBUS-TBNA and ¹⁸F-FDG PET/CT for radiotherapy target volume definition
    In: Radiation Oncology Jg. 16 (2021) Nr. 1, 176
  • Guberina, Maja; Pöttgen, Christoph; Metzenmacher, Martin; Wiesweg, Marcel; Schuler, Martin; Aigner, Clemens; Ploenes, Till; Umutlu, Lale; Gauler, Thomas; Darwiche, Kaid; Stamatis, Georgios; Theegarten, Dirk; Hautzel, Hubertus; Jentzen, Walter; Guberina, Nika; Herrmann, Ken; Eberhardt, Wilfried E.E.; Stuschke, Martin
    Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non-Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 12, S. 1684 - 1691
  • Wessolly, Michael; Stephan-Falkenau, Susann; Streubel, Anna; Werner, Robert; Borchert, Sabrina; Griff, Sergej; Mairinger, Elena; Walter, Robert F. H.; Bauer, Torsten; Eberhardt, Wilfried E. E.; Blum, Torsten G.; Schmid, Kurt Werner; Kollmeier, Jens; Mairinger, Thomas; Mairinger, Fabian D.
    A novel epitope quality-based immune escape mechanism reveals patient’s suitability for immune checkpoint inhibition
    In: Cancer Management and Research Jg. 12 (2020) S. 7881 - 7890
  • Wiesweg, Marcel; Herold, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; Reis, Henning; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Herrmann, Ken; Nensa, Felix; Schildhaus, Hans-Ulrich; Schuler, Martin
    Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutation
    In: Lung Cancer Jg. 139 (2020) S. 165 - 168
  • Guberina, Nika; Pöttgen, Christoph; Schuler, Martin; Guberina, Maja; Stamatis, Georgios; Plönes, Till; Krebs, Bettina; Metzenmacher, Martin; Theegarten, Dirk; Gauler, Thomas; Jöckel, Karl-Heinz; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Eberhardt, Wilfried
    Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment : Only few risks left to improve
    In: European Journal of Cancer (EJC) Jg. 138 (2020) S. 156 - 168
  • Reissig, Timm M.; Sara, Linda; Ting, Saskia; Reis, Henning; Metzenmacher, Martin; Eberhardt, Wilfried; Zaun, Gregor; Herold, Thomas; Aigner, Clemens; Darwiche, Kaid; Stuschke, Martin; Schildhaus, Hans-Ulrich; Schuler, Martin; Wiesweg, Marcel
    ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancer
    In: Lung Cancer Jg. 149 (2020) S. 10 - 16
  • Stockhammer, Paul; Ho, Cassandra Su Lyn; Hegedus, Luca; Lotz, Gabor; Molnár, Eszter; Bankfalvi, Agnes; Herold, Thomas; Kalbourtzis, Stavros; Ploenes, Till; Eberhardt, Wilfried; Schuler, Martin; Aigner, Clemens; Schramm, Alexander; Hegedus, Balazs
    HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model
    In: Lung Cancer Jg. 144 (2020) S. 20 - 29
  • Borchert, Sabrina; Suckrau, Pia-Maria; Walter, Robert F. H.; Wessolly, Michael; Mairinger, Elena; Steinborn, Julia; Hegedus, Balazs; Hager, Thomas; Herold, Thomas; Eberhardt, Wilfried; Wohlschläger, Jeremias; Aigner, Clemens; Bankfalvi, Agnes; Schmid, Kurt Werner; Mairinger, Fabian D.
    Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma
    In: Scientific Reports Jg. 10 (2020) Nr. 1, S. 18677
  • Wiesweg, Marcel; Mairinger, Fabian; Reis, Henning; Goetz, Moritz; Kollmeier, Jens; Misch, Daniel; Stephan-Falkenau, Susann; Mairinger, Thomas; Walter, Robert F.H.; Hager, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; Zaun, Gregor; Köster, Johannes; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Schmid, Kurt Werner; Rahmann, Sven; Schuler, Martin
    Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context
    In: European Journal of Cancer (EJC) Jg. 140 (2020) S. 76 - 85
  • Walter, Robert Fred Henry; Sydow, Saskia Roxanne; Berg, Erika; Kollmeier, Jens; Christoph, Daniel; Christoph, Sandra; Eberhardt, Wilfried; Mairinger, Thomas; Wohlschläger, Jeremias; Schmid, Kurt Werner; Mairinger, Fabian Dominik
    Bortezomib sensitivity is tissue dependent and high expression of the 20S proteasome precludes good response in malignant pleural mesothelioma
    In: Cancer Management and Research Jg. 11 (2019) S. 8711 - 8720
  • Pöttgen, Christoph; Kleinhans, J.; Gauler, Thomas; Wrede, Karsten; Schuler, Martin; Aigner, Clemens; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin
    Cerebral Recurrence after trimodal Therapy of Patients with locally advanced NSCLC - Prognostic Factors and prognostic Importance
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 195 (2019) Nr. Suppl. 1, S. S66 - S67
  • Borchert, Sabrina; Wessolly, Michael; Schmeller, Jan; Mairinger, Elena; Kollmeier, Jens; Hager, Thomas; Mairinger, Thomas; Herold, Thomas; Christoph, Daniel; Walter, Robert F. H.; Eberhardt, Wilfried; Plönes, Till; Wohlschläger, Jeremias; Aigner, Clemens; Schmid, Kurt Werner; Mairinger, Fabian D.
    Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro
    In: BMC Cancer Jg. 19 (2019) Nr. 1, 108
  • Field, John K.; Dekoning, Harry; Oudkerk, Mattijs; Anwar, Sadia; Mulshine, James; Pastorino, Ugo; Eberhardt, Wilfried; Prosch, Helmut
    Implementation of lung cancer screening in Europe: Challenges and potential solutions : Summary of a multidisciplinary roundtable discussion
    In: ESMO Open Jg. 4 (2019) Nr. 5, S. 000577
  • Wiesweg, Marcel; Mairinger, Fabian; Reis, Henning; Goetz, Moritz; Walter, Robert; Hager, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; McCutcheon, A.; Köster, J.; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Schmid, Kurt Werner; Rahmann, Sven; Schuler, Martin
    Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancer
    In: Annals of Oncology Jg. 30 (2019) Nr. 4, S. 655 - 657
  • Guberina, Maja; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Theegarten, Dirk; Jentzen, Walter; Herrmann, Ken; Pöttgen, Christoph
    Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules : analysis of the ESPATUE randomized phase 3 trial
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) Nr. 7, S. 1439 - 1447
  • Borchert, Sabrina; Suckrau, Pia-Maria; Wessolly, Michael; Mairinger, Elena; Hegedus, Balazs; Hager, Thomas; Herold, Thomas; Eberhardt, Wildfried E. E.; Wohlschläger, Jeremias; Aigner, Clemens; Bankfalvi, Agnes; Schmid, Kurt Werner; Walter, Robert F. H.; Mairinger, Fabian D.
    Screening of Pleural Mesothelioma Cell Lines for Kinase Activity May Identify New Mechanisms of Therapy Resistance in Patients Receiving Platin-Based Chemotherapy
    In: Journal of Oncology (2019) 2902985
  • Eberhardt, Wilfried; Stuschke, Martin; Aigner, Clemens; Pogorzelski, M.
    Aktueller Stand der Diagnostik und Therapie des nichtkleinzelligen Lungenkarzinoms (NSCLC) im Stadium III
    In: Der Onkologe Jg. 24 (2018) Nr. 12, S. 974 - 982
  • Griesinger, Frank; Roeper, Julia; Pöttgen, Christoph; Willborn, Kay C.; Eberhardt, Wilfried
    Brain metastases in ALK-positive NSCLC - Time to adjust current treatment algorithms
    In: OncoTarget Jg. 9 (2018) Nr. 80, S. 35181 - 35194
  • Rami-Porta, Ramón; Eberhardt, Wilfried
    Clinical implications of the innovations in the primary tumour and metastasis of the 8th edition of the TNM classification for lung cancer
    In: Journal of Thoracic Disease Jg. 10 (2018) Nr. Suppl. 22, S. S2682 - S2685
  • Blumenthal, Gideon M.; Bunn, Paul A.; Chaft, Jamie E.; McCoach, Caroline E.; Perez, Edith A.; Scagliotti, Giorgio V.; Carbone, David P.; Aerts, Hugo J.W.L.; Aisner, Dara L.; Bergh, Jonas; Berry, Donald A.; Jarkowski, Anthony; Botwood, Nicholas; Cross, Darren A.E.; Diehn, Max; Drezner, Nicole L.; Doebele, Robert C.; Blakely, Collin M.; Eberhardt, Wilfried; Felip, Enriqueta; Gianni, Luca; Keller, Steven P.; Leavey, Patrick J.; Malik, Shakun; Pignatti, Francesco; Prowell, Tatiana M.; Redman, Mary W.; Rizvi, Naiyer A.; Rosell, Rafael; Rusch, Valerie; de Ruysscher, Dirk; Schwartz, Lawrence H.; Sridhara, Rajeshwari; Stahel, Rolf A.; Swisher, Stephen; Taube, Janis M.; Travis, William D.; Keegan, Patricia; Wiens, Jacinta R.; Wistuba, Ignacio I.; Wynes, Murry W.; Hirsch, Fred R.; Kris, Mark G.
    Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer
    In: Journal of Thoracic Oncology Jg. 13 (2018) Nr. 12, S. 1818 - 1831
  • Nicholson, Andrew G.; Tsao, Ming S.; Travis, William D.; Patil, Deepa T.; Galateau-Salle, Francoise; Marino, Mirella; Dacic, Sanja; Beasley, Mary Beth; Butnor, Kelly J.; Yatabe, Yasushi; Pass, Harvey I.; Rusch, Valerie W.; Detterbeck, Frank C.; Asamura, Hisao; Rice, Thomas W.; Rami-Porta, Ramon; Goldstraw, Peter; Ball, David; Beer, David; Beyruti, Ricardo; Bolejack, Vanessa; Chansky, Kari; Crowley, John; Eberhardt, Wilfried; Edwards, John; Giroux, Dorothy; Gleeson, Fergus; Groome, Patti; Huang, James; Kennedy, Catherine; Kim, Jhingook; Kim, Young Tae; Kingsbury, Laura; Kondo, Haruhiko; Krasnik, Mark; Kubota, Kaoru; Lerut, Toni; Lyons, Gustavo; Marom, Edith M.; Van Meerbeeck, Jan; Mitchell, Alan; Nakano, Takashi; Nowak, Anna; Peake, Michael; Rosenzweig, Kenneth; Ruffini, Enrico; Saijo, Nagahiro; Van Schil, Paul; Sculier, Jean-Paul; Shemanski, Lynn; Stratton, Kelly; Suzuki, Kenji; Tachimori, Yuji; Thomas, Charles F.; Turrisi, Andrew; Vansteenkiste, Johan; Watanabe, Hirokazu; Wu, Yi-Long; Bankier, Alex; Flieder, Douglas B.; Goo, Jin Mo; MacMahon, Heber; Naidich, David; Powell, Charles A.; Prokop, Mathias; Arenberg, Douglas A.; Donington, Jessica S.; Franklin, Wilbur A.; Girard, Nicolas; Mazzone, Peter J.; Tanoue, Lynn T.; Baas, Paul; Erasmus, Jeremy; Hasegawa, Seiki; Inai, Kouki; Kernstine, Kemp; Kindler, Hedy; Krug, Lee; Nackaerts, Kristiaan; Rice, David; Falkson, Conrad; Filosso, Pier Luigi; Giaccone, Giuseppe; Kondo, Kazuya; Lucchi, Marco; Okumura, Meinoshin; Blackstone, Eugene; Geisinger, Kim; Borczuk, Alain; Warth, Arne; Lantuejoul, Sylvie; Russell, Prudence; Thunnissen, Erik; Marchevsky, Alberto; Mino-Kenudson, Mari; Botling, Johan; Noguchi, Masayuki; Kerr, Keith; Hirsch, Fred R.; Chirieac, Lucian; Wistuba, Ignacio I.; Moreira, Andre; Chung, Jin-Haeng; Chou, Teh Ying; Bubendorf, Lukas; Chen, Gang; Pelosi, Giuseppe; Poleri, Claudia
    Eighth edition staging of thoracic malignancies : Implications for the reporting pathologist
    In: Archives of Pathology and Laboratory Medicine Jg. 142 (2018) Nr. 5, S. 645 - 661
  • Mucha, M. A.; Abu Jawad, Jehad; Gauler, Thomas; Eberhardt, Wilfried; Guberina, M.; Stuschke, Martin; Pöttgen, Christoph
    Final Re-irradiation of Patients with NSCLC after primary high-dose Local Therapy
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 194 (2018) Nr. Suppl.1, S. S59
  • Ishiba, Toshiyuki; Hoffmann, Andreas-Claudius; Usher, Joshua; Elshimali, Yahya; Sturdevant, Todd; Dang, Mai; Jaimes, Yolanda; Tyagi, Rama; Gonzales, Ronald; Grino, Mary; Pinski, Jacek K.; Barzi, Afsaneh; Raez, Luis E.; Eberhardt, Wilfried; Theegarten, Dirk; Lenz, Heinz-Josef; Uetake, Hiroyuki; Danenberg, Peter V.; Danenberg, Kathleen
    Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types
    In: Biochemical and Biophysical Research Communications (BBRC) Jg. 500 (2018) Nr. 3, S. 621 - 625
  • Mairinger, Fabian D.; Schmeller, Jan; Borchert, Sabrina; Wessolly, Michael; Mairinger, Elena; Kollmeier, Jens; Hager, Thomas; Mairinger, Thomas; Christoph, Daniel; Walter, Robert F.H.; Eberhardt, Wilfried; Plönes, Till; Wohlschläger, Jeremias; Jasani, Bharat; Schmid, Kurt Werner; Bankfalvi, Agnes
    Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy
    In: OncoTarget Jg. 9 (2018) Nr. 32, S. 22254 - 22268
  • Walter, Robert F. H.; Werner, Robert; Wessolly, Michael; Mairinger, Elena; Borchert, Sabrina; Schmeller, Jan; Kollmeier, Jens; Mairinger, Thomas; Hager, Thomas; Bankfalvi, Agnes; Christoph, Daniel; Eberhardt, Wilfried; Plönes, Till; Aigner, Clemens; Schmid, Kurt Werner; Wohlschläger, Jeremias; Mairinger, Fabian D.
    Inhibition of MDM2 via Nutlin-3A : A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53
    In: Journal of Oncology (2018) 1986982
  • Nadjm, S.; Pöttgen, Christoph; Gauler, Thomas; Exner, J. P.; Krebs, B.; Cheufou, D.; Umutlu, Lale; Deuschl, C.; Darwiche, Kaid; Schuler, Martin; Eberhardt, Wilfried; Stuschke, Martin
    Investigations of Long-term Survivors with locally advanced NSCLC on Morbidity of curative Therapy - Analysis of neurocognitive Effects
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 194 (2018) Nr. Suppl. 1, S. 110
  • Reis, Henning; Metzenmacher, Martin; Goetz, Moritz; Savvidou, Nikoleta; Darwiche, Kaid; Aigner, Clemens; Herold, Thomas; Eberhardt, Wilfried; Skiba, Charlotte; Hense, Jörg; Virchow, Isabel; Westerwick, Daniela; Bogner, Simon; Ting, Saskia; Kasper, Stefan; Stuschke, Martin; Nensa, Felix; Herrmann, Ken; Hager, Thomas; Schmid, Kurt Werner; Schuler, Martin; Wiesweg, Marcel
    MET Expression in Advanced Non–Small-Cell Lung Cancer : Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy
    In: Clinical Lung Cancer Jg. 19 (2018) Nr. 4, S. e441 - e463
  • Guberina, M.; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Pöttgen, Christoph
    Pre-therapeutic metabolic Tumor Volume (MTV) in (18) F-FDG-PET/CT as a prognostic Factor in Patients with Stage IIIA-IIIB NSCLC before Trimodal Therapy or definitive Chemoradiotherapy - Results of Phase 3 Study
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 194 (2018) Nr. Suppl.1, S. S41 - S42
  • Guberina, M.; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Cheufou, D.; Schuler, Martin; Stamatis, Georgios; Pöttgen, Christoph
    Pretreatment metabolic volume in PET : Prognostic in lung cancer? German ESPATUE randomised phase3trial
    In: Radiotherapy and Oncology (The Green Journal) Jg. 127 (2018) Nr. Suppl.1, S. S253 - S254
  • Wessolly, Michael; Walter, Robert F. H.; Vollbrecht, Claudia; Werner, Robert; Borchert, Sabrina; Schmeller, Jan; Mairinger, Elena; Herold, Thomas; Streubel, Anna; Christoph, Daniel; Eberhardt, Wilfried E. E.; Kollmeier, Jens; Mairinger, Thomas; Schmid, Kurt W.; Wohlschläger, Jeremias; Hager, Thomas; Mairinger, Fabian D.
    Processing Escape Mechanisms Through Altered Proteasomal Cleavage of Epitopes Affect Immune Response in Pulmonary Neuroendocrine Tumors
    In: Technology in Cancer Research & Treatment (TCRT) Jg. 17 (2018)
  • Oezkan, Filiz; Herold, Thomas; Darwiche, Kaid; Eberhardt, Wilfried; Worm, Karl; Christoph, Daniel; Wiesweg, Marcel; Freitag, Lutz; Schmid, Kurt Werner; Theegarten, Dirk; Hager, Thomas; Koenig, Michael J.; He, Kai; Taube, Christian; Schuler, Martin; Breitenbücher, Frank
    Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma
    In: Clinical Lung Cancer Jg. 19 (2018) Nr. 6, S. e879 - e884
  • Pöttgen, Christoph; Abu Jawad, Jehad; Gauler, Thomas; Guberina, M.; Darwiche, Kaid; Aigner, Clemens; Theegarten, Dirk; Schuler, Martin; Eberhardt, Wilfried; Stuschke, Martin
    Sequential Dose Escalation Study NEOAHA for locally advanced NSCLC - Phase I-Results of Stage 1 (Integrated Boost-Radiation in neoadjuvant Therapy)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 194 (2018) Nr. Suppl. 1, S. S23 - S24
  • Pogorzelski, M.; Eberhardt, Wilfried
    Therapie des nichtkleinzelligen Lungenkarzinoms im Stadium I–IIIC : Multimodale Konzepte mit kurativer Intention
    In: Best Practice Onkologie Jg. 13 (2018) Nr. 3, S. 156 - 169
  • Schuette, Wolfgang; Schirmacher, Peter; Eberhardt, Wilfried; Muehlenhoff, Lars; Dietel, Manfred; Thomas, Michael; Zirrgiebel, Ute
    Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany : an observational study
    In: BMC Cancer Jg. 18 (2018) S. 135
  • Eberhardt, Wilfried; Garassino, M. C.; Rizvi, N. A.; Janne, P. A.; Christoph, Daniel; Peters, S.; Toh, C. K.; Kurata, T.; Costa, E. C.; Koczywas, M.; Felip, E.; Chaft, J.; Qiu, J.; Kowanetz, M.; Coleman, S.; Mocci, S.; Sandler, A.; Gettinger, S.; Johnson, M. L.
    Atezolizumab as 1L therapy for advanced NSCLC in PD-L1-selected patients : updated ORR, PFS and OS data from the BIRCH study
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 5, S. 220
  • Eberhardt, Wilfried
    Checkpointinhibitoren beim nichtkleinzelligen Lungenkarzinom
    In: Der Onkologe Jg. 23 (2017) Nr. 10, S. 838 - 844
  • Griesinger, Frank; Eberhardt, Wilfried; Marschner, Norbert; Janicke, Martina; Hipper, Anette; Karatas, Aysun; Sebastian, Martin; Thomas, Michael; Schirmacher, Peter
    Clinical Research Platform into Molecular Testing, Treatment, Outcome (CRISP) : A Prospective German Registry in Stage IV NSCLC AIO-TRK-0315
    In: Journal of Thoracic Oncology Jg. 12 (2017) Nr. Suppl. 1, S. S385
  • Griesinger, F.; Eberhardt, Wilfried; Marschner, N.; Janicke, M.; Fleitz, A.; Spring, L.; Sahlmann, J.; Karatas, A.; Hipper, A.; Weichert, W.; Sebastian, M.; Thomas, M.
    Clinical Research platform Into molecular testing, treatment and outcome of non-Small cell lung carcinoma Patients (CRISP) : a prospective German Registry in stage IV NSCLC AIO-TRK-0315)
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5, S. 1385TiP
  • Griesinger, F.; Eberhardt, Wilfried; Marschner, N.; Janicke, M.; Fleitz, A.; Sahlmann, J.; Karatas, A.; Hipper, A.; Sebastian, M.; Thomas, M.
    Clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma Patients (CRISP) : A prospective German registry in stage IV NSCLC, AIO-TRK-0315
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 2, S. 125P
  • Pöttgen, Christoph; Eberhardt, Wilfried; Stamatis, Georgios; Stuschke, Martin
    Definitive radiochemotherapy versus surgery within multimodality treatment in stage III non-small cell lung cancer (NSCLC) - a cumulative meta-analysis of the randomized evidence
    In: OncoTarget Jg. 8 (2017) Nr. 25, S. 41670 - 41678
  • Christopoulos, Petros D.; Engel-Riedel, Walburga; Grohé, Christian M.; Kropf-Sanchen, Cornelia; von Pawel, Joachim V.; Gütz, Sylvia; Kollmeier, Jens; Eberhardt, Wilfried; Ukena, Dieter; Baum, Volker; Nimmrich, I.; Sieder, Christian; Schnabel, Philipp Albert; Serke, Monika Heidi Ursel; Thomas, Michael G.
    Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma : A multicenter phase II trial
    In: Annals of Oncology Jg. 28 (2017) Nr. 8, S. 1898 - 1902
  • Mucha, M. A.; Pöttgen, Christoph; Moliavi, S.; Abu Jawad, Jehad; Gauler, Thomas; Christoph, Daniel; Eberhardt, Wilfried; Stuschke, Martin
    Factors for the long-term Survival of Patients with NSCLC in the Stage of oligometastatic Disease after definitive Local Therapy
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 193 (2017) Nr. Suppl. 1, S. 58
  • Eberhardt, Wilfried; Rebmann, Vera; Rizvi, N.; Antonia, S. J.; Planchard, D.; Cappuzzo, F.; Mazieres, J.; Zalcman, G.; Lena, H.; Wolf, J.; Horn, L.; Stinchcombe, T.; Dy, G.; Blackwood-Chirchir, A.; Jin, C.; Geese, W. J.; Ramalingam, S. S.
    First signal-finding study of soluble HLA-G and -E (sHLA-G/E) as potential prognostic markers of clinical outcome in advanced, refractory squamous-cell NSCLC (SCC) treated with nivolumab (NIVO) : checkMate 063
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3, S. 218 - 219
  • Guberina, M.; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Heinzelmann, F.; Cheufou, D.; Kimmich, M.; Friedel, G.; Schmidberger, H.; Darwiche, Kaid; Jendrossek, Verena; Schuler, Martin; Stamatis, Georgios; Pöttgen, Christoph
    Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer : secondary analysis of a randomized trial
    In: Annals of Oncology Jg. 28 (2017) Nr. 5, S. 1084 - 1089
  • Wiesweg, Marcel; Eberhardt, Wilfried; Reis, Henning; Ting, Saskia; Savvidou, Nikoleta; Skiba, Charlotte; Herold, Thomas; Christoph, Daniel; Meiler, Johannes; Worm, Karl; Kasper, Stefan; Theegarten, Dirk; Hense, Jörg; Hager, Thomas; Darwiche, Kaid; Oezkan, Filiz; Aigner, Clemens; Welter, Stefan; Kühl, Hilmar; Stuschke, Martin; Schmid, Kurt Werner; Schuler, Martin
    High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer
    In: Journal of Thoracic Oncology Jg. 12 (2017) Nr. 1, S. 54 - 64
  • Schmidberger, H.; Heiss, M.; Eberhardt, Wilfried
    Immunonkologie : Die sanfte Revolution der Krebsmedizin?
    In: Der Onkologe Jg. 23 (2017) Nr. 10, S. 790 - 792
  • Pöttgen, Christoph; Eberhardt, Wilfried; Stuschke, Martin
    Importance of neoadjuvant Radiotherapy in the trimodal Approach in the Treatment of locally advanced, potentially resectable NSCLC - a Meta-Analysis
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 193 (2017) Nr. Suppl. 1, S. S62 - S63
  • Guberina, M.; Pöttgen, Christoph; Abu Jawad, Jehad; Guberina, N.; Bucksch, D.; Cho, S. H.; Eberhardt, Wilfried; Stuschke, Martin;
    Intermodaler Vergleich von EBUS-TBNA, 18F-FDG PET/CT im Rahmen der Bestrahlungsplanung beim Lokal-fortgeschrittenen Nichtkleinzelligen Lungenkarzinom (Stadium II-IIIB)
    23. Jahrestagung der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2017 ; 14. - 18. Juni 2017, Berlin, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 193 (2017) Nr. Suppl. 1: Abstracts DEGRO 2017, S. S20
  • Thomas, M.; Kohlhaufl, M.; Reck, M.; Engel-Riedel, W.; Kortsik, C.; Bullinger, L.; Schneider, C. P.; Felip, E.; Brahmer, J.; Vokes, E.; Gettinger, S.; Geese, W.; Yoon, D.; Healey, D.; Li, A.; Eberhardt, Wilfried
    Long-term outcomes with nivolumab in patients with previously treated advanced Non-Small Cell Lung Cancer (NSCLC)
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3, S. 137
  • Griesinger, F.; Eberhardt, Wilfried; Nusch, A.; Reiser, M.; Losem, C.; Ketzler-Henkel, S.; Zahn, M. O.; Marschner, N.; Janicke, M.; Fleitz, A.; Spring, L.; Sahlmann, J.; Hipper, A.; Karatas, A.; de Wit, M.; Metzenmacher, M.; Waller, C. F.; Kern, J.; Weichert, W.; Sebastian, M.; Thomas, M.
    Molecular testing, frequency of molecular alterations and first-line treatment of patients with non-small cell lung carcinoma (NSCLC) in Germany. First results from the prospective German Registry CRISP (AIO-TRK-0315)
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. 3, S. 136 - 136
  • Horn, Leora; Spigel, David R.; Vokes, Everett E.; Holgado, Esther; Ready, Neal; Steins, Martin; Poddubskaya, Elena; Borghaei, Hossein; Felip, Enriqueta; Paz-Ares, Luis; Pluzanski, Adam; Reckamp, Karen L.; Burgio, Marco A.; Kohlhäeufl, Martin; Waterhouse, David; Barlesi, Fabrice; Antonia, Scott; Arrieta, Oscar; Fayette, Jérôme; Crinò, Lucio; Rizvi, Naiyer; Reck, Martin; Hellmann, Matthew D.; Geese, William J.; Li, Ang; Blackwood-Chirchir, Anne; Healey, Diane; Brahmer, Julie; Eberhardt, Wilfried
    Nivolumab versus docetaxel in previously treated patients with advanced non-small-cell lung cancer : Two-year outcomes from two randomized, open-label, phase III Trials (CheckMate 017 and CheckMate 057)
    In: Journal of Clinical Oncology (JCO) Jg. 35 (2017) Nr. 35, S. 3924 - 3933
  • Pöttgen, Christoph; Guberina, M.; Abu Jawad, Jehad; Gauler, Thomas; Cordes, S.; Heinzelmann, F.; Schmidberger, H.; Darwiche, Kaid; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin
    Prognostic Significance of Mean Lung Dose (MLD) in the dose-enhanced Radiochemotherapy of Local Advanced NSCLC - Analysis of ESPATU's Definitive Radiochemotherapy Arm
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 193 (2017) Nr. 1, S. 20
  • Oezkan, Filiz; Herold, Thomas; Darwiche, Kaid; Eberhardt, Wilfried; Christoph, Daniel; Worm, Karl; Freitag, Lutz; Schmid, Kurt Werner; Hager, Thomas; Breitenbücher, Frank; Schuler, Martin
    Rapid and Highly Sensitive EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA Specimen of Lung Adenocarcinoma
    In: Journal of Thoracic Oncology Jg. 12 (2017) Nr. Suppl. 1, S. S1201 - S1201
  • Soria, Jean-Charles; Fülöp, A.; Maciel, C.; Fischer, J.R.; Girotto, G.; Lago, S.; Smit, E.; Ostoros, G.; Eberhardt, Wilfried; Lishkovska, P.; Lovick, S.; Mariani, G.; McKeown, A.; Kilgour, E.; Smith, P.; Bowen, K.; Kohlmann, A.; Carlile, D.J.; Jänne, P.A.
    SELECT-2: A phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer
    In: Annals of Oncology Jg. 28 (2017) Nr. 12, S. 3028 - 3036
  • Zarogoulidis, Paul; Petanidis, Savvas; Domvri, Kalliopi; Kioseoglou, Efrosini; Anestakis, Doxakis; Freitag, Lutz; Zarogoulidis, Konstantinos; Hohenforst-Schmidt, Wolfgang; Eberhardt, Wilfried
    Autophagy inhibition upregulates CD4(+) tumor infiltrating lymphocyte expression via miR-155 regulation and TRAIL activation
    In: Molecular Oncology Jg. 10 (2016) Nr. 10, S. 1516 - 1531
  • Köhler, Jens; Schuler, Martin; Gauler, Thomas; Nöpel-Dünnebacke, Stefanie; Ahrens, Maike; Hoffmann, Andreas-Claudius; Kasper, Stefan; Nensa, Felix; Gomez, Benedikt; Hahnemann, Maria; Breitenbücher, Frank; Cheufou, Danjouma; Özkan, Filiz; Darwiche, Kaid; Hoiczyk, Mathias; Reis, Henning; Welter, Stefan; Eberhardt, Wilfried; Eisenacher, Martin; Teschler, Helmut; Stamatis, Georgios; Schmiegel, Wolff; Hahn, Stephan Albrecht; Baraniskin, Alexander
    Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
    In: Journal of Cancer Research and Clinical Oncology Jg. 142 (2016) Nr. 4, S. 795 - 805
  • Schuette, W; Dietel, M; Thomas, M; Eberhardt, Wilfried; Griesinger, F; Zirrgiebel, U; Radke, S; Schirmacher, P
    Exonabhängige Subgruppenanalyse der nicht-interventionellen REASON-Studie : PFS und OS beim EGFR-mutierten NSCLC mit Behandlung von Gefitinib versus Chemotherapie
    In: Pneumologie Jg. 70 (2016) Nr. 8, S. 514 - 521
  • Heukamp, L; Menon, R; Müller, J; Lakis, S; Netchaeva, M; Griesinger, F; Eberhardt, Wilfried; Heuckmann, J M
    NEOliquid : Detection of KIF5B-RET fusions in liquid biopsy samples
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. Suppl. 4, S. 82 - 83
  • Eberhardt, Wilfried; Mitchell, Alan; Rami-Porta, Ramon
    Reply to the Letter to the Editor by Hendriks et al.
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 3, S. e43 - e44
  • Pöttgen, Christoph; Gauler, Thomas; Bellendorf, Alexander; Guberina, Maja; Bockisch, Andreas; Schwenzer, Nina; Heinzelmann, Frank; Cordes, Sebastian; Schuler, Martin H; Welter, Stefan; Stamatis, Georgios; Friedel, Godehard; Darwiche, Kaid; Jöckel, Karl-Heinz; Eberhardt, Wilfried; Stuschke, Martin
    Standardized Uptake Decrease on [18F]-Fluorodeoxyglucose Positron Emission Tomography After Neoadjuvant Chemotherapy Is a Prognostic Classifier for Long-Term Outcome After Multimodality Treatment : Secondary Analysis of a Randomized Trial for Resectable Stage IIIA/B Non-Small-Cell Lung Cancer
    In: Journal of Clinical Oncology (JCO) Jg. 34 (2016) Nr. 21, S. 2526 - 2533
  • Schuette, W; Eberhardt, Wilfried; Waller, C; Schirmacher, P; Dietel, M; Zirrgiebel, U; Radke, S; Thomas, M
    Subgruppenanalyse aus der nicht-interventionellen Beobachtungsstudie REASON : PFS und OS gemäß Alter, Raucherstatus, Geschlecht und histologischem Subtyp unter Verwendung von Gefitinib bzw. chemotherapeutischer Behandlung bei NSCLC-Patienten
    In: Pneumologie Jg. 70 (2016) Nr. 9, S. 579 - 588
  • Goldstraw, Peter; Chansky, Kari; Crowley, John; Rami-Porta, Ramon; Asamura, Hisao; Eberhardt, Wilfried; Nicholson, Andrew G; Groome, Patti; Mitchell, Alan; Bolejack, Vanessa; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee
    The IASLC Lung Cancer Staging Project : Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 1, S. 39 - 51
  • Detterbeck, Frank C; Nicholson, Andrew G; Franklin, Wilbur A; Marom, Edith M; Travis, William D; Girard, Nicolas; Arenberg, Douglas A; Bolejack, Vanessa; Donington, Jessica S; Mazzone, Peter J; Tanoue, Lynn T; Rusch, Valerie W; Crowley, John; Asamura, Hisao; Rami-Porta, Ramón; IASLC Staging and Prognostic Factors Committee; Eberhardt, Wilfried
    The IASLC Lung Cancer Staging Project : Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 5, S. 639 - 650
  • Detterbeck, Frank C; Bolejack, Vanessa; Arenberg, Douglas A; Crowley, John; Donington, Jessica S; Franklin, Wilbur A; Girard, Nicolas; Marom, Edith M; Mazzone, Peter J; Nicholson, Andrew G; Rusch, Valerie W; Tanoue, Lynn T; Travis, William D; Asamura, Hisao; Rami-Porta, Ramón; IASLC Staging and Prognostic Factors Committee; Advisory Boards; Multiple Pulmonary Sites Workgroup; Eberhardt, Wilfried
    The IASLC Lung Cancer Staging Project : Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 5, S. 681 - 692
  • Travis, William D; Asamura, Hisao; Bankier, Alexander A; Beasley, Mary Beth; Detterbeck, Frank; Flieder, Douglas B; Goo, Jin Mo; MacMahon, Heber; Naidich, David; Nicholson, Andrew G; Powell, Charles A; Prokop, Mathias; Rami-Porta, Ramón; Rusch, Valerie; van Schil, Paul; Yatabe, Yasushi; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee; Eberhardt, Wilfried
    The IASLC Lung Cancer Staging Project : Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 8, S. 1204 - 1223
  • Pass, Harvey; Giroux, Dorothy; Kennedy, Catherine; Ruffini, Enrico; Cangir, Ayten K; Rice, David; Asamura, Hisao; Waller, David; Edwards, John; Weder, Walter; Hoffmann, Hans; van Meerbeeck, Jan P; Rusch, Valerie W; Goldstraw, Peter; Rami-Porta, Ramón; Ball, David; Beer, David; Beyruti, Ricardo; Bolejack, Vanessa; Chansky, Kari; Crowley, John; Detterbeck, Frank; Eberhardt, Wilfried; Edwards, John; Galateau-Sallé, Françoise; Gleeson, Fergus; Groome, Patti; Huang, James; Kim, Jhingook; Kim, Young Tae; Kingsbury, Laura; Kondo, Haruhiko; Krasnik, Mark; Kubota, Kaoru; Lerut, Antoon; Lyons, Gustavo; Marino, Mirella; Marom, Edith M; van Meerbeeck, Jan; Mitchell, Alan; Nakano, Takashi; Nicholson, Andrew G; Nowak, Anna; Peake, Michael; Rosenzweig, Kenneth; Rusch, Valerie; Saijo, Nagahiro; Van Schil, Paul; Sculier, Jean-Paul; Shemanski, Lynn; Stratton, Kelly; Suzuki, Kenji; Tachimori, Yuji; Thomas, Charles F; Travis, William; Tsao, Ming S; Turrisi, Andrew; Vansteenkiste, Johan; Watanabe, Hirokazu; Wu, Yi-Long; Baas, Paul; Erasmus, Jeremy; Hasegawa, Seiki; Inai, Kouki; Kernstine, Kemp; Kindler, Hedy; Krug, Lee; Nackaerts, Kristiaan; Falkson, Conrad; Filosso, Pier Luigi; Giaccone, Giuseppe; Kondo, Kazuya; Lucchi, Marco; Okumura, Meinoshin; Blackstone, Eugene
    The IASLC Mesothelioma Staging Project : Improving Staging of a Rare Disease Through International Participation
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 12, S. 2082 - 2088
  • Nowak, Anna K.; Chansky, Kari; Rice, David C; Pass, Harvey I; Kindler, Hedy L; Billé, Andrea; Rintoul, Robert C; Batirel, Hasan F; Thomas, Charles F; Friedberg, Joseph; Cedres, Susana; de Perrot, Marc; Rusch, Valerie W; Goldstraw, Peter; Rami-Porta, Ramón; Asamura, Hisao; Ball, David; Beer, David; Beyruti, Ricardo; Bolejack, Vanessa; Crowley, John; Detterbeck, Frank; Eberhardt, Wilfried; Edwards, John; Galateau-Sallé, Françoise; Giroux, Dorothy; Gleeson, Fergus; Groome, Patti; Huang, James; Kennedy, Catherine; Kim, Jhingook; Kim, Young Tae; Kingsbury, Laura; Kondo, Haruhiko; Krasnik, Mark; Kubota, Kaoru; Lerut, Antoon; Lyons, Gustavo; Marino, Mirella; Marom, Edith M; van Meerbeeck, Jan; Mitchell, Alan; Nakano, Takashi; Nicholson, Andrew G; Peake, Michael; Rosenzweig, Kenneth; Ruffini, Enrico; Saijo, Nagahiro; Van Schil, Paul; Sculier, Jean-Paul; Shemanski, Lynn; Stratton, Kelly; Suzuki, Kenji; Tachimori, Yuji; Thomas, Charles F; Travis, William; Tsao, Ming S; Turrisi, Andrew; Watanabe, Hirokazu; Wu, Yi-Long; Baas, Paul; Erasmus, Jeremy; Hasegawa, Seiki; Inai, Kouki; Kernstine, Kemp; Krug, Lee; Nackaerts, Kristiaan; Pass, Harvey; Falkson, Conrad; Filosso, Pier Luigi; Giaccone, Giuseppe; Kondo, Kazuya; Lucchi, Marco; Okumura, Meinoshin; Blackstone, Eugene
    The IASLC Mesothelioma Staging Project : Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 12, S. 2089 - 2099
  • Detterbeck, Frank C.; Franklin, Wilbur A.; Nicholson, Andrew G.; Girard, Nicolas; Arenberg, Douglas A.; Travis, William D.; Mazzone, Peter J.; Marom, Edith M.; Donington, Jessica S.; Tanoue, Lynn T.; Rusch, Valerie W.; Asamura, Hisao; Rami-Porta, Ramón; IASLC Staging and Prognostic Factors Committee; Eberhardt, Wilfried
    The IASLC lung cancer staging project : Background data and proposed criteria to distinguish separate primary lung cancers from metastatic foci in patients with two lung tumors in the forthcoming eighth edition of the TNM classification for lung cancer
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 5, S. 651 - 665
  • Nicholson, Andrew; Rami-Porta, Ramon; van Meerbeeck, Jan; Eberhardt, Wilfried; Turrisi, Andrew; Kubota, Kaoru; Beyruti, Ricardo; Crowley, John; Chansky, Kari
    The International Association for the Study of Lung Cancer Lung Cancer Staging Project : Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 3, S. 300 - 311
  • Kreuter, Michael; Thomas, Michael; Griesinger, Frank; Stamatis, Georgios; Graeter, Thomas; Schumann, Christian; Thomeer, Michiel; Neumann, Silke; Reck, Martin; Frickhofen, Norbert; Serke, Monika; Kollmeier, Jens; Zabeck, Heike; Eberhardt, Wilfried; Fischer, Jürgen R.; Vansteenkiste, Johan; Engel-Riedel, Walburga
    Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study)
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 1, S. 85 - 93
  • Kowanetz, M.; Li, Z.; Peters, S.; Kurata, T.; Johnson, M.; Eberhardt, Wilfried; Mocci, S.; Sandler, A.; Garassino, M.; Rizvi, N.A.; Toh, C.K.; Besse, B.; Janne, P.A.
    16LBA Phase II, single-arm trial (BIRCH) of atezolizumab as first-line or subsequent therapy for locally advanced or metastatic PD-L1-selected non-small cell lung cancer (NSCLC)
    In: European Journal of Cancer Jg. 51 (2015) Nr. Suppl. 3, S. S717 - S718
  • Eberhardt, Wilfried; De Ruysscher, Dirk De M.; Weder, Walter; Le Péchoux, Cécile; De Leyn, Paul De J.; Hoffmann, Hans Jürgen H.; Westeel, Virginie; Stahel, Rolf Arno; Felip, Enriqueta; Peters, Solange; Panel Members
    2nd ESMO Consensus Conference in Lung Cancer : locally advanced stage III non-small-cell lung cancer
    In: Annals of oncology Jg. 26 (2015) Nr. 8, S. 1573 - 1588
  • Spigel, David R.; Reckamp, Karen L.; Rizvi, Naiyer A.; Poddubskaya, Elena; West, Howard Jack; Eberhardt, Wilfried; Baas, Paul; Antonia, Scott Joseph; Pluzanski, Adam; Vokes, Everett E; Holgado, Esther; Waterhouse, David Michael; Ready, Neal; Gainor, Justin F.; Aren, Osvaldo Rudy; Horn, Leora; Paz-Ares, Luis; Baudelet, Christine; Lestini, Brian Joseph; Brahmer, Julie R.
    A phase III study (CheckMate 017) of nivolumab (NIVO; anti-programmed death-1 [PD-1]) vs docetaxel (DOC) in previously treated advanced or metastatic squamous (SQ) cell non-small cell lung cancer (NSCLC)
    In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 15_suppl, S. 8009
  • Pöttgen, Christoph; Abu Jawad, Jehad; Gkika, Eleni; Freitag, Lutz; Lübcke, Wolfgang; Welter, Stefan; Gauler, Thomas; Schuler, Martin; Eberhardt, Wilfried; Stamatis, Georgios; Stuschke, Martin
    Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomy
    In: Journal of Thoracic Disease Jg. 7 (2015) Nr. 3, S. 264 - 272
  • Kelly, Karen; Altorki, Nasser K; Eberhardt, Wilfried; O'Brien, Mary E R; Spigel, David R; Crinò, Lucio; Tsai, Chun-Ming; Kim, Joo-Hang; Cho, Eun Kyung; Hoffman, Philip C; Orlov, Sergey V; Serwatowski, Piotr; Wang, Jiuzhou; Foley, Margaret A; Horan, Julie D; Shepherd, Frances A
    Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT) : A Randomized, Double-Blind, Phase III Trial
    In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 34, S. 4007 - 4014
  • Shepherd, Frances A.; Eberhardt, Wilfried; Altorki, Nasser K.; O'Brien, Mary E. R; Wang, Joe; Wu, Jun; Gill, Stan; Iwata, Kenneth; Richardson, Frank C.; Horan, Julie D.; Foley, Margaret A.; Kelly, Karen
    Common and rare EGFR mutations (EGFRm) in the RADIANT trial : Final follow-up with 5 year data
    In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 15_suppl, S. 7539
  • Eberhardt, Wilfried
    Concurrent chemoradiotherapy in stage III non-small-cell lung cancer : what is the best regimen?
    In: Journal of clinical oncology Jg. 33 (2015) Nr. 6, S. 532 - 533
  • Schütte, Wolfgang H. W.; Schirmacher, Peter; Eberhardt, Wilfried; Fischer, Jürgen R.; von der Schulenburg, J.-Matthias Graf; Mezger, Jörg; Schumann, Christian; Serke, Monika; Zaun, Silke; Dietel, Manfred; Thomas, Michael
    EGFR mutation status and first-line treatment in patients with stage III/IV non-small cell lung cancer in Germany : An observational study
    In: Cancer Epidemiology, Biomarkers & Prevention Jg. 24 (2015) Nr. 8, S. 1254 - 1261
  • O'Brien, Mary E. R.; Kelly, Karen; Altorki, Nasser K.; Eberhardt, Wilfried; Spigel, David R.; Crino, Lucio; Tsai, Chun-Ming; Kim, Joo-Hang; Cho, Eun Kyung; Hoffman, Philip C.; Keshavjee, Shaf; Orlov, Sergey; Serwatowski, Piot; Wang, Joe; Foley, Margaret A.; Horan, Julie D.; Shepherd, Frances A.
    Final follow-up (f/u) results from RADIANT : A randomized double blind phase 3 trial of adjuvant erlotinib (E) versus placebo (P) following complete tumor resection in patients (pts) with stage IB-IIIA EGFR positive (IHC/FISH) non-small cell lung cancer (N
    In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 15_suppl, S. 7540
  • Gore, Martin; Szczylik, C.; Porta, C.; Bracarda, S.; Bjarnason, G. A.; Oudard, S.; Lee, S.-H.; Haanen, J.; Castellano, D.; Vrdoljak, E.; Schöffski, P.; Mainwaring, P.; Hawkins, R. E.; Crinò, L.; Kim, T. M.; Carteni, G.; Eberhardt, Wilfried; Zhang, K.; Fly, K.; Matczak, E.; Lechuga, M. J.; Hariharan, S.; Bukowski, R.
    Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma
    In: British Journal of Cancer (BJC) Jg. 113 (2015) Nr. 1, S. 12 - 19
  • Reis, Henning; Herold, Thomas; Ting, S.; Worm, Karl Heinz; Huber, U.; Christoph, Daniel; Eberhardt, Wilfried; Kostbade, K.; Kasper, Stefan; Stamatis, Georgios; Welter, Stefan; Darwiche, Kaid; Karpf-Wissel, Rüdiger; Theegarten, Dirk; Schmidt, K. W.; Schuler, Martin; Wiesweg, Marcel
    HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas
    In: Lung Cancer Jg. 88 (2015) Nr. 1, S. 34 - 41
  • Eberhardt, Wilfried; Stuschke, Martin
    Multimodal treatment of non-small-cell lung cancer
    In: The Lancet Jg. 386 (2015) Nr. 9998, S. 1018 - 1020
  • Brahmer, Julie; Reckamp, Karen L; Baas, Paul; Crinò, Lucio; Eberhardt, Wilfried; Poddubskaya, Elena; Antonia, Scott; Pluzanski, Adam; Vokes, Everett E; Holgado, Esther; Waterhouse, David; Ready, Neal; Gainor, Justin; Arén Frontera, Osvaldo; Havel, Libor; Steins, Martin; Garassino, Marina C; Aerts, Joachim G; Domine, Manuel; Paz-Ares, Luis; Reck, Martin; Baudelet, Christine; Harbison, Christopher T; Lestini, Brian; Spigel, David R
    Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
    In: The New England Journal of Medicine Jg. 373 (2015) Nr. 2, S. 123 - 135
  • Joerger, Markus; Von Pawel, Joachim; Kraff, Stefanie; Fischer, Juergen R; Eberhardt, Wilfried; Gauler, Thomas; Mueller, Lothar; Reinmuth, Niels; Reck, Martin; Kimmich, Martin; Mayer, Frank; Kopp, Hans-Georg; Behringer, Dirk M.; Ko, Yon-Dschun; Frueh, Martin; Hilger, Ralf A.; Roessler, Max; Moritz, Berta; Jaehde, Ulrich
    Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin in advanced non-small cell lung cancer (NSCLC) patient
    In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 15_suppl, S. 8051
  • Eberhardt, Wilfried; Pöttgen, Christoph; Gauler, Thomas; Friedel, Godehard; Veit, Stefanie; Heinrich, Vanessa; Welter, Stefan; Budach, Wilfried; Spengler, Werner; Kimmich, Martin; Fischer, Berthold; Schmidberger, Heinz; De Ruysscher, Dirk; Belka, Claus; Cordes, Sebastian; Hepp, Rodrigo; Lütke-Brintrup, Diana; Lehmann, Nils; Schuler, Martin; Jöckel, Karl-Heinz; Stamatis, Georgios; Stuschke, Martin
    Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)
    In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 35, S. 4194 - 4201
  • Pöttgen, Christoph; Stuschke, Martin; Graupner, Britta; Theegarten, Dirk; Gauler, Thomas; Jendrossek, Verena; Freitag, Lutz; Abu Jawad, Jehad; Gkika, Eleni; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, Matthias; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried
    Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factors
    In: BMC Cancer Jg. 15 (2015) Nr. 1, S. 363
  • Eberhardt, Wilfried
    Reply to D.A. Palma et al and A. Addeo et al
    In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 26, S. 2929 - 2930
  • Eberhardt, Wilfried; Mitchell, Alan; Crowley, John; Kondo, Haruhiko; Kim, Young Tae; Turrisi, Andrew; Goldstraw, Peter; Rami-Porta, Ramon
    The IASLC Lung Cancer Staging Project : Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer
    In: Journal of Thoracic Oncology Jg. 10 (2015) Nr. 11, S. 1515 - 1522
  • Rami-Porta, Ramón; Bolejack, Vanessa; Crowley, John; Ball, David; Kim, Jhingook; Lyons, Gustavo; Rice, Thomas; Suzuki, Kenji; Thomas, Charles F.; Travis, William D.; Wu, Yi-Long; IASLC Staging and Prognostic Factors Committee, Advisory Boards and Participating Institutions.; Eberhardt, Wilfried
    The IASLC lung cancer staging project : Proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer
    In: Journal of Thoracic Oncology Jg. 10 (2015) Nr. 7, S. 990 - 1003
  • Krug, Lee M.; Kindler, Hedy L.; Calvert, Hilary; Manegold, Christian; Tsao, Anne S.; Fennell, Dean; Öhman, Ronny; Plummer, Ruth; Eberhardt, Wilfried; Fukuoka, Kazuya; Gaafar, Rabab M.; Lafitte, Jean-Jacques; Hillerdal, Gunnar; Chu, Quincy; Buikhuisen, Wieneke A.; Lubiniecki, Gregory M.; Sun, Xing; Smith, Margaret; Baas, Paul
    Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014) : a phase 3, double-blind, randomised, placebo-controlled trial
    In: The lancet oncology Jg. 16 (2015) Nr. 4, S. 447 - 456
  • Vansteenkiste, J.; Crinò, L.; Dooms, C.; Douillard, J. Y.; Faivre-Finn, C.; Lim, E.; Rocco, G.; Senan, S.; van~Schil, P.; Veronesi, G.; Stahel, R.; Peters, S.; Felip, E.; Kerr, K.; Besse, B.; Eberhardt, Wilfried; Edelman, M.; Mok, T.; O'Byrne, K.; Novello, S.; Bubendorf, L.; Marchetti, A.; Baas, P.; Reck, M.; Syrigos, K.; Paz-Ares, L.; Smit, E.; Meldgaard, P.; Adjei, A.; Nicolson, M.; Weder, W.; Ruysscher, D. de; Le~Pechoux, C.; Leyn, P. de; Westeel, V.
    2nd ESMO consensus conference on lung cancer : Early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
    In: Annals of Oncology Jg. 25 (2014) Nr. 8, S. 1462 - 1474
  • Kelly, K.; Altorki, N. K.; Eberhardt, Wilfried; O'Brien, MER; Spigel, D. R.; Crino, L.; Tsai, C. M.; Kim, J. H.; Cho, E. K.; Szczesna, A.; Burghuber, O.; Hoffman, P. C.; Keshavjee, S.; Orlov, S.; Serwatowski, P.; Wang, J. Z.; Foley, M. A.; Horan, J. D.; Park, J. W.; Shepherd, F. A.; Tarceva Radiant Investigator Grp
    A randomized, double-blind phase 3 trial of adjuvant erlotinib (E) versus placebo (P) following complete tumor resection with or without adjuvant chemotherapy in patients (pts) with stage IB-IIIA EGFR positive (IHC/FISH) non-small cell lung cancer (NSCLC) : RADIANT results
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 7501
  • Shepherd, F. A.; Altorki, N. K.; Eberhardt, Wilfried; O'Brien, Mary; Spigel, D. R.; Crino, L.; Tsai, C. M.; Kim, J. H.; Cho, E. K.; Szczesna, A.; Burghuber, O.; Hoffman, P. C.; Keshavjee, S.; Orlov, S.; Serwatowski, P.; Wang, J. Z.; Foley, M. A.; Horan, J. D.; Richardson, F. C.; Kelly, K.; Tarceva Radiant Investigator Grp
    Adjuvant erlotinib (E) versus placebo (P) in non-small cell lung cancer (NSCLC) patients (pts) with tumors carrying EGFR-sensitizing mutations from the RADIANT trial
    In: Journal of Clinical Oncology (JCO) Jg. 32 S (2014) Nr. 15, S. 7513
  • O'Brien, MER; Eberhardt, Wilfried; Altorki, N. K.; Spigel, D. R.; Crino, L.; Tsai, C. M.; Cho, E. K.; Kim, J. H.; Szczesna, A.; Hoffman, P. C.; Burghuber, O.; Keshavjee, S.; Orlov, S.; Serwatowski, P.; Wang, J. Z.; Foley, M. A.; Horan, J. D.; Park, J. W.; Shepherd, F. A.; Kelly, K.; Tarceva Radiant Investigator Grp
    Analysis of treatment duration and safety of adjuvant erlotinib (E) versus placebo (P) after surgery in patients (pts) with non-small cell lung cancer (NSCLC) : RADIANT trial
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 7535
  • Christoph, Daniel; Reyna-Asuncion, Bernadette; Hassan, Biftu; Tran, Cindy; Maltzman, Julia D; O'Shannessy, Daniel J; Gauler, Thomas; Wohlschläger, Jeremias; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R
    Assessment of Folate Receptor-α and Epidermal Growth Factor Receptor Expression in Pemetrexed-Treated Non–Small-Cell Lung Cancer Patients
    In: Clinical Lung Cancer Jg. 15 (2014) Nr. 5, S. 320 - 330.e3
  • Deppermann, Karl-Matthias; Hoffmann, Hans; Eberhardt, Wilfried
    Benefits and Risks of Lung Cancer Screening
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 3, S. 58 - 66
  • Gauler, Thomas; Espenhain, L.; Hoiczyk, M.; Nel, I.; Parr, A.; Roder, J.; Schuler, Martin; Eberhardt, Wilfried; Roder, H.; Hoffmann, Andreas-Claudius
    Correlation of proteomics and first-line platinum-based chemotherapy in stage NSCLC in a large single-center cohort
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl.,
  • Nensa, Felix; Stattaus, Jörg; Morgan, Bruno; Horsfield, Mark A.; Soria, Jean-Charles; Besse, Benjamin; Gounant, Valerie; Khalil, Antoine; Seng, Katja; Fischer, Berthold; Krissel, Heiko; Laurent, Dirk; Christoph, Daniel; Eberhardt, Wilfried; Gauler, Thomas
    Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancer
    In: Future Oncology Jg. 10 (2014) Nr. 5, S. 823 - 833
  • Eberhardt, Wilfried; Mitchell, Paul; Schiller, Joan H.; Brown, Michael P.; Thomas, Michael; Mills, Glenn; Jehl, Valentine; Urva, Shveta R.; De Leo, Jeffrey J.; Gogov, Sven; Papadimitrakopoulou, Vasiliki
    Feasibility of adding everolimus to carboplatin and paclitaxel, with or without bevacizumab, for treatment-naive, advanced non-small cell lung cancer
    In: Investigational New Drugs: The Journal of New Anticancer Agents Jg. 32 (2014) Nr. 1, S. 123 - 134
  • Kreuter, M.; Vansteenkiste, J.; Herth,~F.~J.~F.; Fischer, J. R.; Eberhardt, Wilfried; Zuna, I.; Reinmuth, N.; Griesinger, F.; Thomas, M.
    Impact and safety of adjuvant chemotherapy on pulmonary function in early stage non-small cell lung cancer
    In: Respiration: International Journal of Thoracic Medicine Jg. 87 (2014) Nr. 3, S. 204 - 210
  • Gkika, E.; Gauler, Thomas; Eberhardt, Wilfried; Stahl, Michael; Stuschke, Martin; Pöttgen, Christoph
    Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus
    In: Diseases of the Esophagus Jg. 27 (2014) Nr. 7, S. 678 - 684
  • Sebastian, M; Niederle, Norbert; Thomas, M; Reck, M; Schmittel, A; Fischer, B; Overbeck, T; Gröschel, A; Deppermann, M; Pirker, R; Huber, R M; Eberhardt, Wilfried; Griesinger, F
    Molekulargenetische Untersuchungen bei fortgeschrittenem nicht-kleinzelligem Lungenkarzinom : praktische Relevanz
    In: Deutsche Medizinische Wochenschrift: DMW Jg. 139 (2014) Nr. 41, S. 2096 - 2100
  • Leijen, S.; Barlesi, F.; Eberhardt, Wilfried; Martinez, G. M.; Dieras, V.; Schellens, JHM; Middleton, M.; Calvo, E.; Paz-Ares, L.; Larkin, J.; Jodrell, D.; Soria, J. C.
    Ocular toxicities observed with MEK inhibitor RO4987655 (CH4987655) in a single agent phase I study with extension in patients with advanced solid tumors
    In: British Journal of Clinical Pharmacology (BJCP) Jg. 78 (2014) Nr. 4, S. 769
  • Sterzing, F.; Eberhardt, Wilfried; Friedel, G.; Pöttgen, Christoph; Rieken, S.
    Oligometastasiertes Lungenkarzinom : Neue prognoserelevante Konzepte
    In: Der Onkologe Jg. 20 (2014) Nr. 10, S. 991 - 997
  • Zimmer, Lisa; Barlesi, Fabrice; Martinez-Garcia, Maria; Dieras, Veronique; Schellens, Jan. H.M.; Spano, Jean-Phillipe; Middleton, Marc R.; Calvo, Emiliano; Paz-Ares, Luiz; Larkin, James; Pacey, Simon; Venturi, Miro; Kraeber-Bodéré, Francoise; Tessier, Jean J. L.; Eberhardt, Wilfried; Paques, Michel; Guarin, Ernesto; Meresse, Valerie; Soria, Jean-Charles
    Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS-RAF mutations
    In: Clinical Cancer Research Jg. 20 (2014) Nr. 16, S. 4251 - 4261
  • Eberhardt, Wilfried; Gauler, Thomas; Pöttgen, Christoph; Friedel, G.; Veit, S.; Heinrich, V.; Welter, Stefan; Spengler, W.; Kimmich, M.; Fischer, B.; Schmidberger, H.; Gkika, E.; Cordes, S.; Hepp, R.; Luetke-Brintrup, D.; Lehmann, Nils; Schuler, Martin; Jöckel, Karl-Heinz; Stamatis, Georgios; Stuschke, Martin; ESPATUE AIO ARO Clinical Trials
    Phase III study of surgery (S) versus definitive concurrent chemoradiotherapy boost (def ccCRTx-BOx) in patients (pts) with operable (OP+) stage IIIA(N2)/selected IIIb (sel IIIB) non-small cell lung cancer (NSCLC) following induction (IND) chemotherapy (CTx) and concurrent CRTx (ESPATUE)
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 7510
  • Chalvatzoulis, E.; Wohlschläger, Jeremias; Hager, T.; Cheufou, D.; Eberhardt, Wilfried; Stamatis, Georgios; Welter, Stefan
    Resection of a Giant Neuroblastoma Misdiagnosed as Atypical Mediastinal Carcinoid
    In: Journal of Thoracic Oncology Jg. 9 (2014) Nr. 1, S. 132 - 134
  • Christoph, Daniel; Eberhardt, Wilfried
    Systemic treatment of malignant pleural mesothelioma: new agents in clinical trials raise hope of relevant improvements
    In: Current Opinion in Oncology Jg. 26 (2014) Nr. 2, S. 171 - 181
  • Butts, C.; Socinski, M. A.; Mitchell, P. L.; Thatcher, N.; Havel, L.; Krzakowski, M.; Nawrocki, S.; Ciuleanu, T.-E.; Bosquée, L.; Trigo, J. M.; Spira, A.; Tremblay, L.; Nyman, J.; Ramlau, R.; Wickart-Johansson, G.; Ellis, P.; Gladkov, O.; Pereira, J. R.; Eberhardt, Wilfried; Helwig, C.; Schröder, A.; Shepherd, F. A.
    Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START) : A randomised, double-blind, phase 3 trial
    In: The Lancet Oncology Jg. 15 (2014) Nr. 1, S. 59 - 68
  • Eberhardt, Wilfried; Gauler, Thomas; Lepechoux, C.; Stamatis, Georgios; Bildat, Stephan; Krbek, T.; Welter, Stefan; Grunenwald, D.; Fischer, B.; Rodrigo, H. D.; Theegarten, Dirk; Le Chevalier, T.; Seeber, Siegfried; Stuschke, Martin; Pöttgen, Christoph
    10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)—A multicenter phase-II trial (CISTAXOL)
    In: Lung Cancer Jg. 82 (2013) Nr. 1, S. 83 - 89
  • Pöttgen, Christoph; Eberhardt, Wilfried; Graupner, Britta; Theegarten, Dirk; Gauler, Thomas; Freitag, Lutz; Abu Jawad, Jehad; Wohlschläger, Jeremias; Welter, Stefan; Stamatis, Georgios; Stuschke, Martin
    Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer : Markedly higher rate of pathologic complete remissions than with conventional fractionation
    In: European Journal of Cancer Jg. 49 (2013) Nr. 9, S. 2107 - 2115
  • Souquet, P. J.; Dietel, M.; Eberhardt, Wilfried; Fournel, P.; Von der Schulenburg, JMG; Locher, C.; Sabourin, J. C.; Schirmacher, P.; Thomas, M.; Schuette, W.
    EGFR mutation and management of advanced non-small cell lung cancer (NSCLC) adenocarcinoma in Germany and France
    In: European Journal of Cancer Jg. 49 (2013) Nr. Suppl. 2, S. 817
  • Ting, Saskia; Mairinger, Fabian D.; Hager, Thomas; Welter, Stefan; Eberhardt, Wilfried; Wohlschläger, Jeremias; Schmid, Kurt Werner; Christoph, Daniel
    ERCC1, MLH1, MSH2, MSH6, and βiII-tubulin: Resistance proteins associated with response and outcome to platinum-based chemotherapy in malignant pleural mesothelioma
    In: Clinical Lung Cancer Jg. 14 (2013) Nr. 5, S. 558 - 567
  • Vansteenkiste, J.; De Ruysscher, D.; Eberhardt, Wilfried; Lim, E.; Senan, S.; Felip, E.; Peters, S.; ESMO Guidelines Working Grp
    Early and locally advanced non-small-cell lung cancer (NSCLC) : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    In: Annals of Oncology Jg. 24 (2013) Nr. Suppl. 6, S. vi89 - vi98
  • Hirsch, F. R.; Jänne, P. A.; Eberhardt, Wilfried; Cappuzzo, F.; Thatcher, N.; Pirker, R.; Choy, H.; Kim, E. S.; Paz-Ares, L.; Gandara, D. R.; Wu, Y. L.; Ahn, M. J.; Mitsudomi, T.; Shepherd, F. A.; Mok, T. S.
    Epidermal Growth Factor Receptor Inhibition in Lung Cancer : Status 2012
    In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. 3, S. 373 - 384
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, Karl; Kasper, Stefan; Tewes, Mitra; Welt, Anja; Richly, Heike; Meiler, Johannes; Bauer, Sebastian; Hense, Jörg; Gauler, Thomas; Köhler, Jens; Eberhardt, Wilfried; Darwiche, Kaid; Freitag, Lutz; Stamatis, Georgios; Breitenbücher, Frank; Wohlschläger, Jeremias; Theegarten, Dirk; Derks, Cordula; Cortes-Incio, Diana; Linden, Gabriele; Skottky, Silke; Lütkes, Peter; Dechene, Alexander; Paul, Andreas; Markus, Peter; Schmid, Kurt Werner; Schuler, Martin
    Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center
    In: European Journal of Cancer (EJC) Jg. 49 (2013) Nr. 15, S. 3076 - 3082
  • Nel, I.; Gauler, Thomas; Eberhardt, Wilfried; Nickel, A. C.; Schuler, Martin; Thomale, Jürgen; Hoffmann, Andreas-Claudius
    Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatment
    In: British Journal of Cancer (BJC) Jg. 109 (2013) Nr. 5, S. 1223 - 1229
  • Rebmann, Vera; Gauler, Thomas; Schott, B.; Schott, P.; Bauer, Sebastian; Opalka, Bertram; Stamatis, Georgios; Eberhardt, Wilfried; Schuler, Martin; Horn, Peter
    Free soluble HLA-G molecules but not exosome-derived soluble HLA-G molecules are of prognostic relevance in lung cancer patients
    In: Tissue Antigens Jg. 81 (2013) Nr. 5, S. 282 - 283
  • Welter, Stefan; Schwan, Alexandra; Cheufou, Danjouma; Darwiche, Kaid; Christoph, Daniel; Eberhardt, Wilfried; Weinreich, Gerhard; Stamatis, Georgios
    Midterm changes in quality of life : A prospective evaluation after open pulmonary metastasectomy
    In: The Annals of Thoracic Surgery Jg. 95 (2013) Nr. 3, S. 1006 - 1011
  • Eberhardt, Wilfried; Gauler, Thomas; Schadendorf, Dirk
    Neue Entwicklungen in der Behandlung von soliden Tumoren mit zielgerichteten Medikamenten. Lunge, Niere, Melanom
    In: Der Onkologe Jg. 19 (2013) Nr. 10, S. 821 - 834
  • Dumitru, Claudia A.; Bankfalvi, Agnes; Gu, Xiang; Eberhardt, Wilfried; Zeidler, Reinhard; Lang, Stephan; Brandau, Sven
    Neutrophils activate tumoral CORTACTIN to enhance progression of orohypopharynx carcinoma
    In: Frontiers in Immunology Jg. 4 (2013) S. 33
  • Knoedler, M.; Gauler, Thomas; Gruenwald, V.; Matzdorff, A.; Schroeder, M.; Dietz, A.; Jordan, W. O.; Arnold, D.; Hennemann, B.; Hofele, C.; Weissinger, F.; Eberhardt, Wilfried; Keilholz, U.
    Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy : A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie
    In: Oncology Jg. 84 (2013) Nr. 5, S. 284 - 289
  • Gauler, Thomas; Besse, B.; Novello, S.; Smit, E. F.; Plummer, E. R.; Delord, J. P.; Nicodemo, M.; Santoro, A.; Barone, C.; Marchetti, P.; Conte, P. F.; De Jonge, M. J.; Awada, A.; Mariani, M.; Jannuzzo, M. G.; Petroccione, A.; Ceruti, R.; Davite, C.; Eberhardt, Wilfried
    Phase II study of danusertib (D) in advanced/metastatic non-small cell lung cancers (NSCLC)
    In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 15 Suppl., S. e19138
  • Gauler, Thomas Christoph; Christoph, Daniel Christian; Fischer, Juergen; Frickhofen, Norbert; Huber, Rudolf; Gonschorek, Christine; Roth, Katrin; Giurescu, Marius; Eberhardt, Wilfried Ernst Erich
    Phase-I study of sagopilone in combination with cisplatin in chemotherapy-naive patients with metastasised small-cell lung cancer
    In: European journal of cancer Jg. 49 (2013) Nr. 11, S. 2461 - 2468
  • Kreuter, Michael; Vansteenkiste, Johan F.; Fischer, Jürgen Richard; Eberhardt, Wilfried; Zabeck, Heike; Kollmeier, Jens; Serke, Monika; Frickhofen, Norbert; Reck, Martin P.; Engel-Riedel, Walburga; Neumann, Silke; Thomeer, Michiel J.; Schumann, Christian; De Leyn, Paul De J.; Graeter, Thomas P.; Stamatis, Georgios; Zuna, Ivan; Griesinger, Frank; Thomas, Michael N.
    Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine : The TREAT study
    In: Annals of Oncology Jg. 24 (2013) Nr. 4, S. 986 - 992
  • Christoph, Daniel; Reyna-Asuncion, Bernadette; Hassan, Biftu; Tran, Cindy; Maltzman, Julia D.; O'Shannessy, Daniel J.; Wynes, Murry W.; Gauler, Thomas; Wohlschläger, Jeremias; Hoiczyk, M.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed
    In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. 1, S. 19 - 30
  • Stahel, R.; Peters, S.; Baas, P.; Brambilla, E.; Cappuzzo, F.; De Ruysscher, D.; Eberhardt, Wilfried; Felip, E.; Fennell, D.; Marchetti, A.; Paz-Ares, L.; Adjei, A. A.
    Strategies for improving outcomes in NSCLC : A look to the future
    In: Lung Cancer Jg. 82 (2013) Nr. 3, S. 375 - 382
  • Tufman, Amanda; Schumann, Christian; Huber, Rudolf M.; Eberhardt, Wilfried; Flentje, Michael; Haug, Alexander; Junker, Klaus; Pfluger, Thomas; Winter, Hauke
    Tumorkonferenz II
    In: Onkologie Jg. 36 (2013) Nr. 6, S. 14 - 16
  • Vansteenkiste, J. F.; Paz-Ares, L.; Eisen, TQG; Heigener, D.; Eberhardt, Wilfried; Thomas, M.; Zhou, C.; Santoro, A.; Lathia, C.; Roder, H.
    A plasma proteomic signature predicts outcomes in a phase 3 study of Gemcitabine (G) plus Cisplatin (C) +/- sorafenib in first line stage IIIB or IV NSCLC
    In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 9, S. 407
  • Christoph, Daniel; Hoffmann, Andreas-Claudius; Gauler, Thomas; Asuncion, Bernadette Reyna; Loewendick, Heike; Peglow, Anja; Hassan, Biftu; Tran, Cindy; Wynes, Murry W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Detection of circulating lung cancer cells with strong thymidylate synthase reactivity in the peripheral blood of a patient with pulmonary adenocarcinoma treated with pemetrexed
    In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 4, S. 766 - 767
  • Drescher, O.; Eberhardt, Wilfried; Prittwitz, R.; Gkika, E.; Korfee, Sönke; Theegarten, Dirk; Welter, Stefan; Krbek, T.; Stamatis, Georgios; Pöttgen, Christoph; Schuler, Martin; Christoph, Daniel
    Distribution pattern of metastases and their associations with survival of malignant pleural mesothelioma patients undergoing different treatment modalities
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 140
  • Pirker, Robert; Pereira, Jose R; Von Pawel, Joachim; Krzakowski, Maciej; Ramlau, Rodryg; Park, Keunchil; De Marinis, Filippo; Eberhardt, Wilfried; Paz-Ares, Luis; Störkel, Stephan; Schumacher, Karl-Maria; Von Heydebreck, Anja; Celik, Ilhan; O'Byrne, Kenneth J
    EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer : analysis of data from the phase 3 FLEX study
    In: The Lancet Oncology Jg. 13 (2012) Nr. 1, S. 33 - 42
  • Schuette, W.; Eberhardt, Wilfried; von der Schulenburg, JMG; Dietel, M.; Schirmacher, P.; Zaun, S.; Thomas, M.
    EGFR mutation analysis from REASON : A registry for the epidemiologic and scientific evaluation of EGFR mutation status in newly diagnosed NSCLC patients stage IIIB/IV
    In: Journal of Clinical Oncology (JCO) Jg. 30 (2012) Nr. Suppl. 15, S. e18016
  • Schuette, W.; Eberhardt, Wilfried; von der Schulenburg, JMG; Dietel, M.; Schirmacher, P.; Fischer, J. R.; Mezger, J.; Schumann, C.; Serke, M.; Zaun, S.; Thomas, M.
    EGFR mutation analysis from the German REASON study - a registry for the epidemiologic and scientific evaluation of EGFR mutation status in newly diagnosed NSCLC patients stage IIIB/IV
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 36
  • Pöttgen, Christoph; Levegrün, Sabine; Abu Jawad, Jehad; Lübcke, Wolfgang; Gkika, E.; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin
    Effektivität und Toxizität von bildgeführter hochkonformaler Bestrahlung multipler zerebraler Metastasen mit/ohne Ganzhirnbestrahlung (WBRT) mittels helikaler Tomotherapie
    In: Strahlentherapie und Onkologie Jg. 188 (2012) Nr. 1 Suppl., S. 41 - 42
  • Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Friedel, G.; Kohlhaufl, M.; Hehr, T.; Budach, W.; Bamberg, M.; Welter, Stefan; Stamatis, Georgios; Fischer, B.; Eberhardt, Wilfried
    Erste Sicherheitsanalyse der prospektiv-randomisierten multizentrischen ESPATÜ-Studie : Keine Signale für unerwartete Adverse Events/Toxizitäten
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 188 (2012) Nr. Suppl. 1, S. 34
  • Christoph, Daniel; Asuncion, Bernadette Reyna; Mascaux, Celine; Tran, Cindy; Lu, Xian; Wynes, Murry W.; Gauler, Thomas; Wohlschläger, Jeremias; Theegarten, Dirk; Neumann, Volker; Hepp, Rodrigo; Welter, Stefan; Stamatis, Georgios; Tannapfel, Andrea; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma
    In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 9, S. 1440 - 1448
  • Eberhardt, Wilfried; Griesinger, Frank; Filipits, Martin; Winter, Hauke
    Frühes Stadium beim nichtkleinzelligen Lungenkarzinom
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 3, S. 6 - 9
  • Welter, Stefan; Grabellus, Florian; Bauer, Sebastian; Schuler, Martin; Eberhardt, Wilfried; Tötsch, M.; Stamatis, Georgios
    Growth patterns of lung metastases from sarcoma : prognostic and surgical implications from histology
    In: Interactive Cardiovascular and Thoracic Surgery Jg. 15 (2012) Nr. 4, S. 612 - 617
  • Kohler, J.; Worm, K.; Gauler, Thomas; Hoiczyk, M.; Theegarten, Dirk; Eberhardt, Wilfried; Hense, Jörg; Breitenbücher, Frank; Schmid, Kurt Werner; Schuler, Martin
    Impact of EGFR mutation status on clinical benefit from BIBW 2992 in patients (PTS) with advanced non-small lung cancer (NSCLC) progressing after chemotherapy (CTX) and erlotinib (E) or gefitinib (G) - a single center experience
    In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 9, S. 437 - 438
  • Pöttgen, Christoph; Graupner, B.; Abu Jawad, Jehad; Gauler, Thomas; Theegarten, Dirk; Wohlschläger, Jeremias; Freitag, Lutz; Welter, Stefan; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin
    Improvement of histopathological Remission after neoadjuvant chemotherapy of accelerated hyperfractionation compared to conventional fractionation in locally advanced NSCLC (stage III)
    In: Strahlentherapie und Onkologie Jg. 188 (2012) Nr. Suppl. 1, S. 96 - 96
  • Sak, Ali; Groneberg, M.; Pöttgen, Christoph; Kuebler, D.; Eberhardt, Wilfried; Stuschke, Martin
    Increased effect of Aurora-B kinase inhibition on endoreplicated non-small lung cancer cell lines
    In: Strahlentherapie und Onkologie Jg. 188 (2012) Nr. 1 Suppl., S. 115
  • Sak, Ali; Stuschke, Martin; Groneberg, Michael; Kübler, Dennis; Pöttgen, Christoph; Eberhardt, Wilfried
    Inhibiting the aurora B kinase potently suppresses repopulation during fractionated irradiation of human lung cancer cell lines
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 84 (2012) Nr. 2, S. 492 - 499
  • Christoph, Daniel; Asuncion, B. R.; Hassan, B.; Maltzman, J.; O'Shannessy, D.; Gauler, Thomas; Wynes, M. W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.
    Investigation of Folate Receptor alpha and Thymidylate Synthase Proteins Expression in metastatic Non-Small Cell Lung Cancer Patients treated with Pemetrexed-based Chemotherapy
    In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 9, Suppl. 4, S. S211 - S212
  • Leijen, Suzanne; Middleton, Mark R.; Tresca, Patricia; Kraeber-Bodéré, Françoise; Dieras, Veronique; Scheulen, Max Ernst; Gupta, Avinash; Lopez-Valverde, Vanesa; Xu, Zhi-Xin; Rueger, Ruediger; Tessier, Jean J. L.; Shochat, Eliezer; Blotner, Steve; Naegelen, Valerie Meresse; Schellens, Jan H. M.; Eberhardt, Wilfried
    Phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of the MEK inhibitor RO4987655 (CH4987655) in patients with advanced solid tumors
    In: Clinical Cancer Research Jg. 18 (2012) Nr. 17, S. 4794 - 4805
  • Gauler, Thomas; Besse, Benjamin; Mauguen, Audrey; Méric, Jean Baptiste; Gounant, Valérie; Fischer, Berthold M.; Overbeck, Tobias R.; Krissel, Heiko; Laurent, Dirk; Tiainen, Marianne; Commo, Frédéric; Soria, Jean-Charles; Eberhardt, Wilfried
    Phase II trial of ptk787/zk 222584 (vatalanib) administered orally once-daily or in two divided daily doses as second-line monotherapy in relapsed or progressing patients with stage iiib/iv non-small-cell lung cancer (nsclc)
    In: Annals of Oncology Jg. 23 (2012) Nr. 3, S. 678 - 687
  • Trarbach, Tanja; Schultheis, Beate; Gauler, Thomas; Schneider, Vesile; Strumberg, Dirk; Eberhardt, Wilfried; Le Scouiller, Stephanie; Marotti, Marcelo; Brown, Kathryn H.; Drevs, Joachim
    Phase i open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumours
    In: Investigational New Drugs: The Journal of New Anticancer Agents Jg. 30 (2012) Nr. 5, S. 1962 - 1971
  • Pirker, R.; Pereira, J.R.; Szczesna, A.; von Pawel, J.; Krzakowski, M.; Ramlau, R.; Vynnychenko, I.; Park, K.; Eberhardt, Wilfried; de Marinis, F.; Heeger, S.; Goddemeier, T.; O'Byrne, K.J.; Gatzemeier, U.
    Prognostic factors in patients with advanced non-small cell lung cancer : Data from the phase III FLEX study
    In: Lung Cancer Jg. 77 (2012) Nr. 2, S. 376 - 382
  • Christoph, Daniel; Asuncion, B. R.; Hassan, B.; Maltzman, J.; O'Shannessy, D.; Gauler, Thomas; Wohlschläger, Jeremias; Wynes, M. W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.
    Significance of Folate Receptor alpha (FRA) and Thymidylate Synthase (TS) expression in metastatic non-small cell lung cancer patients treated with pemetrexed-based chemotherapy
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 34
  • Gottschling, Sandra; Herpel, Esther; Eberhardt, Wilfried; Heigener, David F.; Fischer, Jürgen R.; Köhne, Claus-Henning; Kortsik, Cornelius; Kuhnt, Thomas; Muley, Thomas; Meister, Michael; Bischoff, Helge G.; Klein, Peter; Moldenhauer, Ines; Schnabel, Philipp A.; Thomas, Michael; Penzel, Roland
    The gefitinib long-term responder (LTR) : a cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)
    In: Lung Cancer Jg. 77 (2012) Nr. 1, S. 183 - 191
  • Wiesweg, Marcel; Kasper, Stefan; Wohlschläger, Jeremias; Ting, Saskia; Skottky, S.; Worm, K.; Derks, C.; Tewes, Mitra; Breitenbücher, Frank; Gauler, Thomas; Eberhardt, Wilfried; Ahrens, M.; Hoiczyk, M.; Meiler, Johannes; Hense, Jörg; Welt, Anja; Theegarten, Dirk; Freitag, Lutz; Kimmig, Rainer; Schmid, Kurt Werner; Schuler, Martin
    VVTZ-Tumorprofil - First results of a preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 204 - 204
  • Christoph, Daniel; Kasper, Stefan; Gauler, Thomas; Loesch, Christian; Engelhard, Marianne; Theegarten, Dirk; Pöttgen, Christoph; Hepp, Rodrigo; Peglow, Anja; Loewendick, Heike; Welter, Stefan; Stamatis, Georgios; Hirsch, Fred R.; Schuler, Martin; Eberhardt, Wilfried; Wohlschläger, Jeremias
    Βv-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer
    In: British Journal of Cancer (BJC) Jg. 107 (2012) Nr. 5, S. 823 - 830
  • Heusner, Till Alexander; Gölitz, Philipp; Hamami, Monia; Eberhardt, Wilfried; Esser, Stefan; Forsting, Michael; Bockisch, Andreas; Antoch, Gerald
    "One-stop-shop" staging : should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
    In: European Journal of Radiology Jg. 78 (2011) Nr. 3, S. 430 - 435
  • Pöttgen, Christoph; Le Pechoux, C.; Gauler, Thomas; Stuschke, Martin; Grunenwald, D. H.; Stamatis, Georgios; Bildat, Stephan; Krbek, T.; Christoph, Daniel; Welter, Stefan; Fischer, B.; Hepp, R.; Theegarten, Dirk; Eberhardt, Wilfried
    10-year long-term survival (LTS) of induction (IND) chemotherapy (CTX) with three cycles cisplatin(P)/paclitaxel(T) followed by concurrent (CC) chemoradiation (CTX/RTX) P/Etoposide (ETO)/45 GY (1.5 GY BID) plus surgery (S) - A multicenter phase-II trial (Cistaxol)
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. 494
  • Hepp, R.; Gauler, Thomas; Pöttgen, Christoph; Korfee, Sönke; Bildat, Stephan; Stamatis, Georgios; Seeber, S.; Wilke, Hansjochen; Budach, V.; Stuschke, Martin; Eberhardt, Wilfried
    15-Year (very) long-term survival (VLTS) and competing risks (CR) analysis of induction (IND) chemotherapy (CTX) with three cycles cisplatin (P) / etoposide (E) followed by concurrent (CC) chemoradiation (CTX/RTX) PE/45 GY (1.5 GY BID) pkus surgery (S) = TRIM
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S.S 492 - S493
  • Schmittel, Alexander; Sebastian, Martin; Fischer von Weikersthal, Ludwig; Martus, Peter; Gauler, Thomas; Kaufmann, Caroline; Hortig, Patricia; Fischer, Jürgen Richard; Link, Hartmut; Binder, Daniel; Fischer, Berthold; Caca, Karel; Eberhardt, Wilfried; Keilholz, Ulrich
    A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancer
    In: Annals of Oncology Jg. 22 (2011) Nr. 8, S. 1798 - 1804
  • Deutschbein, T.; Unger, Nicole; Yüce, Ali; Eberhardt, Wilfried; Gauler, Thomas; Lahner, Harald; Mann, Klaus; Petersenn, Stephan
    Chemotherapy in Patients with Progressive, Undifferentiated Neuroendocrine Tumors : A Single-Center Experience
    In: Hormone and Metabolic Research Jg. 43 (2011) Nr. 12, S. 838 - 843
  • Eberhardt, Wilfried; Stuschke, Martin
    Combined modality treatment, especially concomitant chemoradiation : Which chemotherapy? Which Radiotherapy fractionation scheme?Toxicities?
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. S214 - S215
  • Eberhardt, Wilfried; Hepp, R.; Gauler, Thomas; Christoph, Daniel; Hoffmann, Andreas-Claudius; Theegarten, Dirk; Welter, Stefan; Schmid, Kurt Werner; Wohlschläger, Jeremias; Passlick, B.; Le Pechoux, C.; Stamatis, Georgios; Stuschke, Martin; Pöttgen, Christoph
    Competing risks analysis and long-term survival (LTS) of patients (PTS) with locally advanced (LAD) stage III non-small- cell lung cancer (NSCLC) treated on sequential trimodality (TM) trials
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. S376 - S377
  • Gauler, Thomas; Theegarten, Dirk; Parr, A.; Schuhr, I.; Schmid, Kurt Werner; Eberhardt, Wilfried; Schuler, Martin; Hoffmann, Andreas-Claudius
    Decrease of circulating tumor cells associates with response to platinum-based chemotherapy in patients with non-small cell lung cancer, but not with small cell lung cancer
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. 1114
  • Thomas, M.; Eberhardt, Wilfried; Graf von der Schulenburg, J.M.; Dietel, M.; Schumacher, P.; Gutendorf, B.; Zirrgiebel, U.; Schütte, W.
    EGFR Mutation Status in NSCLC Patients Stage IIIB/IV in Germany -Initial Results From a German Registry
    In: European Journal of Cancer Jg. 47 (2011) Nr. Suppl. 1, S. S596
  • Eberhardt, Wilfried; Senan, S.; Weder, W.; Faivre-Finn, C.; Vansteenkiste, J.
    Early and locally advanced disease
    In: Lung Cancer Jg. 71 (2011) Nr. Suppl. 2, S. 2
  • Sak, Ali; Stuschke, Martin; Groneberg, M.; Pöttgen, Christoph; Kubler, D.; Eberhardt, Wilfried
    Effect of Aurora-B kinase inhibition on radiation induced cell-cycle checkpoint activation and cell death in non-small lung cancer cell lines
    In: Strahlentherapie und Onkologie Jg. 187 (2011) Nr. Suppl. 1, S. 123
  • Christoph, DanielC; Kasper, Stefan; Gauler, ThomasC; Breitenbücher, Frank; Engelhard, Marianne; Theegarten, Dirk; Pöttgen, Christoph; Hepp, Rodrigo; Peglow, Anja; Loewendick, Heike; Hirsch, FredR; Schuler, Martin; Eberhardt, Wilfried; Wohlschläger, Jeremias
    Evaluation of Betav-Tubulin expression as novel predictive biomarker for clinical benefit from treatment with taxanes in non-small cell lung cancer
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. 1078
  • Christoph, Daniel; Gauler, Thomas; Engelhard, M.; Theegarten, Dirk; Pöttgen, Christoph; Hepp, R.; Schuler, Martin; Hirsch, F.; Eberhardt, Wilfried; Wohlschläger, Jeremias
    Evaluation of betaV-tubulin expression as novel predictive biomarker for clinical benefit from treatment with taxanes in non-small cell lung cancer (NSCLC)
    In: European Journal of Cancer (EJC) Jg. 47 (2011) Nr. Suppl. 4, S. 14
  • Gatzemeier, Ulrich; von Pawel, Joachim; Vynnychenko, Ihor; Zatloukal, Petr; de Marinis, Filippo; Eberhardt, Wilfried; Paz-Ares, Luis; Schumacher, Karl-Maria; Goddemeier, Thomas; O'Byrne, Kenneth J; Pirker, Robert
    First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy : A subgroup analysis of data from the FLEX phase 3 study
    In: The Lancet Oncology Jg. 12 (2011) Nr. 1, S. 30 - 37
  • Pöttgen, Christoph; Levegrun, S.; Abu Jawad, Jehad; Wittig, Andrea; Hepp, R.; Gkika, E.; Grannaß, Andreas; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin
    Hypofractionated image-guided radiotherapy (HF-IGRT) cerebral metastases by means of helical Tomotherapy
    In: Strahlentherapie und Onkologie Jg. 187 (2011) Nr. Suppl. 1, S. 19 - 19
  • Christoph, DanielC; Wohlschläger, Jeremias; Neumann, Volker; Gauler, ThomasC; Pöttgen, Christoph; Peglow, Anja; Tannapfel, Andrea; Schuler, Martin; Hirsch, FredR; Eberhardt, Wilfried; Theegarten, Dirk
    Impact of dihydrofolate reductase expression for clinical benefit from pemetrexed in malignant pleural mesothelioma
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. S1052 - S1053
  • Gauler, Thomas; Pöttgen, Christoph; Wagner, H.; Korfee, Sönke; Hepp, R.; Stamatis, Georgios; Pawel, J. von; Passlick, B.; Budach, V.; Wilke, Hansjochen; Seeber, S.; Stuschke, Martin; Eberhardt, Wilfried
    Long-term survival (LTS) and competing risks within a prospective multi center German randomized trial comparing induction chemotherapy (CTx) followed by concurrent (cc) chemoradiation (CTx/RTx) plus surgery (SURG; TRIMODALITY) supplemented by PCI versus local treatment (Tx) alone (SURG + RTx) in operable IIIA NSCLC.
    In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 7042
  • Gauler, Thomas; Pöttgen, Christoph; Korfee, Sönke; Wagner, H.; Hepp, R.; Stamatis, Georgios; Christoph, Daniel; Passlick, B.; Budach, V.; Seeber, S.; Wilke, Hansjochen; Stuschke, Martin; Eberhardt, Wilfried
    Long-term survival (LTS) and competing risks within a prospective multicenter german randomized trial comparing induction (IND) chemotherapy (CTX) followed by concurrent (CC) chemoradiation (CTX/RTX) plus surgery (S) (= Trimodality) supplemented by PCI VE
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. 495
  • Eberhardt, Wilfried; Gauler, Thomas; Le Pechoux, C.; Hepp, R.; Welter, Stefan; Fischer, B.; Bildat, Stephan; Grunenwald, D.; Stamatis, Georgios; Stuschke, Martin; Pöttgen, Christoph
    Long-term survival (S) of induction chemotherapy (CTx) with three cycles cisplatin (cis)/paclitaxel (pac) followed by concurrent (cc) chemoradiation (CTx/RTx) cis/etoposide (eto) and 45 Gy (1.5 Gy bid) plus surgery (SURG) : Phase II results (CISTAXOL)
    In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 7047
  • Hepp, R.; Pöttgen, Christoph; Gauler, Thomas; Erichsen, Patricia; Le Pechoux, C.; Grunenwald, D.; Welter, Stefan; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried
    Long-term survival results and prognostic factor analysis of two consecutive trimodality Phase-II trials in stage IIIA(N2) and selected stage IIIB non-small-cell lung cancer (NSCLC)
    In: Strahlentherapie und Onkologie Jg. 187 (2011) Nr. Suppl. 1, S. 68 - 69
  • Therasse, P.; Vansteenkiste, J. F.; Zielinski, M.; Pas, T. M. de; Atanackovic, D.; Sequist, L. V.; Vallieres, E.; Swisher, S.; Adams, S.; Passlick, B.; Eberhardt, Wilfried; Grunenwald, D.; Mok, T.; Boyer, M.; Katz, A.; Douillard, J.; Debois, M.; Brichard, V. G.; Altorki, N. K.
    MAGRIT phase III trial : MAGE-A3 antigen-specific cancer immunotherapy (ASCI) as adjuvant therapy in patients with completely resected stage IB-IIIA NSCLC
    In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. TPS210
  • Eberhardt, Wilfried; Gauler, Thomas; Welter, Stefan; Krbek, Thomas; Stuschke, Martin; Pöttgen, Christoph
    Multimodale Therapie des lokal-fortgeschrittenen nichtkleinzelligen Lungenkarzinoms
    In: Der Onkologe Jg. 17 (2011) Nr. 8, S. 691 - 701
  • Leijen, S.; Middleton, M. R.; Tresca, P.; Kraeber-Bodere, F.; Dieras, V.; Scheulen, Max Ernst; Tessier, J.; Xu, Z. X.; Shochat, E.; Walz, A.; Deutsch, J.; Blotner, S.; Lopez Valverde, V.; Naegelen, V. M.; Schellens, J. H. M.; Eberhardt, Wilfried
    Phase I (Ph) safety, pharmacodynamic (PD), and pharmacokinetic (PK) trial of a pure MEK inhibitor (i), RO4987655, in patients with advanced /metastatic solid tumor
    In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 3017
  • Christoph, DanielC; Mascaux, Celine; Wynes, MurryW; Asuncion, Bernadette; Wohlschläger, Jeremias; Theegarten, Dirk; Gauler, Thomas; Neumann, Volker; Pöttgen, Christoph; Tran, Cindy; Tannapfel, Andrea; Schuler, Martin; Eberhardt, Wilfried; Hirsch, FredR
    Predictive value of thymidylate synthase and Folypoly-Glutamate Synthease for clinical benefit from pemetrexed in malignant pleural mesothelioma
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. S1092 - S1093
  • Christoph, Daniel; Mascaux, C.; Wynes, M. W.; Reyna Asuncion, B.; Wohlschläger, Jeremias; Theegarten, Dirk; Gauler, Thomas; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.
    Predictive value of thymidylate synthase and folylpoly-glutamate synthetase for clinical benefit from pemetrexed in malignant pleural mesothelioma
    In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 7024
  • Goeckenjan, G.; Sitter, Helmut; Thomas, Michael; Branscheid, Detlev; Flentje, Michael; Griesinger, Frank; Niederle, N.; Stuschke, Martin; Blum, Torsten; Deppermann, Karl-Matthias; Ficker, Joachim H.; Freitag, Lutz; Lübbe, Andreas Stephan; Reinhold, Thomas; Späth-Schwalbe, Ernst; Ukena, Dieter; Wickert, Martin; Wolf, M.; Andreas, Stefan; Auberger, Thomas; Baum, Richard Paul; Baysal, B.; Beuth, Joseph; Bickeböller, Heike; Böcking, Alfred; Bohle, Rainer Maria; Brüske, Irene; Burghuber, Otto; Dickgreber, Nicolas; Diederich, Stefan; Dienemann, Hendrick; Eberhardt, Wilfried; Eggeling, Stephan; Fink, Thomas; Fischer, Berthold; Franke, M.; Friedel, Godehard; Gauler, Thomas; Gütz, Sylvia; Hautmann, Hubert; Hellmann, Andreas; Hellwig, Dirk; Herth, Felix; Heußel, Claus Peter; Hilbe, Wolfgang; Hoffmeyer, Frank; Horneber, Markus; Huber, Rudolf Maria; Hübner, Jutta; Kauczor, Hans Ulrich; Kirchbacher, Klaus; Kirsten, Detlef; Kraus, Thomas; Lang, Susanne Maria; Martens, Uwe Marc; Mohn-Staudner, Andrea; Müller, Klaus Michael; Müller-Nordhorn, Jacqueline; Nowak, Dennis Alexander; Ochmann, Uta; Passlick, Bernward; Petersen, Iver; Pirker, Robert; Pokrajac, Boris; Reck, Martin; Riha, Susanne; Rübe, Christian; Schmittel, Alexander; Schönfeld, Nicolas; Schütte, Wolfgang; Serke, Monika; Stamatis, Georgios; Steingräber, Maria; Steins, Martin; Stoelben, Erich; Swoboda, Lothar; Teschler, Helmut; Tessen, Hans Werner; Weber, Matthias; Werner, Andreas; Wichmann, H.-E.; Irlinger Wimmer, E.; Witt, Christian; Worth, Heinrich
    Prevention, diagnosis, therapy, and follow-up of lung cancer : interdisciplinary guideline of the German respiratory society and the German cancer society abridged version
    In: Pneumologie Jg. 65 (2011) Nr. 8, S. e51 - e75
  • Ramalingam, S.; Spigel, D.; Steins, M.; Engelman, J.; Novello, S.; Eberhardt, Wilfried; Schneider, C.; Crino, L.; Janne, P. A.; Liu, L.; Chen, D.; Brownstein, C.; Reck, M.
    R1507, a monoclonal antibody to insulin-like growth factor receptor-1A (IGF-1R), in combination with erlotinib for advanced stage non-small cell lung cancer (NSCLC) : A placebo-controlled, randomized phase II study
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. 605
  • Ramalingam, Suresh S.; Spigel, David R.; Chen, David; Steins, Martin B.; Engelman, Jeffrey A.; Schneider, Claus-Peter; Novello, Silvia; Eberhardt, Wilfried; Crino, Lucio; Habben, Kai; Liu, Lian; Jänne, Pasi A.; Brownstein, Carrie M.; Reck, Martin
    Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non–Small-Cell Lung Cancer
    In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 34, S. 4574 - 4580
  • Hirsh, Vera; Paz-Ares, Luis; Boyer, Michael; Rosell, Rafael; Middleton, Gary; Eberhardt, Wilfried; Szczesna, Aleksandra; Reiterer, Pavel; Saleh, Mansoor; Arrieta, Oscar; Bajetta, Emilio; Webb, Roy T.; Raats, Johannes; Benner, Rebecca J.; Fowst, Camilla; Meech, Sandra J.; Readett, David; Schiller, Joan H.
    Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer
    In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 19, S. 2667 - 2674
  • Kreuter, M.; Vansteenkiste, J. F.; Fischer, J. R.; Eberhardt, Wilfried; Zabeck, H.; Kollmeier, Hans-Joachim; Serke, M. H.; Frickhofen, N.; Reck, M.; Engel-Riedel, W.; Neumann, S.; Thomeer, M.; Schumann, C.; Deleyn, P.; Graeter, T.; Stamatis, Georgios; Zuna, I.; Griesinger, F.; Thomas, M.
    Randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed (CPx) versus cisplatin and vinorelbine (CVb) : TREAT
    In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 7002
  • Ramalingam, S. S.; Spigel, D. R.; Steins, M.; Engelman, J. A.; Schneider, C.; Novello, S.; Eberhardt, Wilfried; Crino, L.; Janne, P. A.; Liu, L.; Brownstein, C. M.; Reck, M.
    Randomized, double-blind, phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor receptor-1 (IGF-1R), for advanced-stage non-small cell lung cancer (NSCLC)
    In: Journal of Clinical Oncology Jg. 29 (2011) Nr. Suppl. 15, -
  • Thomas, M.; Eberhardt, Wilfried; von der Schulenburg, JMG; Dietel, M.; Schirmacher, P.; Gutendorf, B.; Schaller, F.; Schutte, W.
    Reason : TKI sensitive EGFR mutation status and associated characteristics of advanced NSCLC patients - Results from a German registry
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 124 - 125
  • Schuette, W.; Eberhardt, Wilfried; Von Der Schulenburg, JMG; Dietel, M.; Schirmacher, P.; Gutendorf, B.; Thomas, M.
    Reason : a registry for the epidemiologic and scientific evaluation of EGFR mutation status in newly diagnosed NSCLC patients stage IIIB/IV in Germany
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. 1244
  • Krzakowski, M.; Heeger, S.; Pereira, J.R.; Paz-Ares, L.; von Pawel, J.; Schnaars, Y.; Eberhardt, Wilfried; Pirker, R.; Goddemeier, T.; Park, K.
    Safety Analysis of Patient Subgroups Defined by Low and High Tumour Epidermal Growth Factor Receptor (EGFR) Expression in FLEX Study Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Receiving Chemotherapy With or Without Cetuximab as First-Line Therapy
    In: European Journal of Cancer Jg. 47 (2011) Nr. Suppl. 1, S. S598
  • Gottschling, S.; Herpel, E.; Eberhardt, Wilfried; Gatzemeier, U.; Fischer, J. R.; Köhne, C. H.; Kortsik, C.; Kuhnt, T.; Muley, T.; Meister, M.; Bischoff, H.; Schnabel, P. A.; Penzel, R.; Thomas, M.
    The Gefitinib Long-Term Responder (LTR) - a cancer stem-like cell story? : Insights from molecular analyses of German long-term responders treated in the iressa expanded access program
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. S966 - S967
  • von Pawel, J.; Eberhardt, Wilfried; Reck, M.; Eschbach, C.; Fischer, J. R.; Schuette, W.; Bohnet, S.; Heeger, S.; Schumacher, K. M.; von Heydebreck, A.; Pirker, R.
    Tumor epidermal growth factor receptor (EGFR) expression as a predictive biomarker of survival in FLEX study patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy plus cetuximab as first-line therapy
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 121
  • Christoph, Daniel; Wittkowski, Lukas; Stattaus, Jörg; Pöttgen, Christoph; Keyvani, Kathy; Gauler, Thomas; Schuler, Martin; Eberhardt, Wilfried
    Very Late and Isolated Leptomeningeal Relapse of a Pulmonary Adenocarcinoma Presenting as Dementia
    In: Onkologie Jg. 34 (2011) Nr. 6, S. 316 - 320
  • O'Byrne, K. J.; Von Pawel, J.; Vynnychenko, I.; Zatloukal, P.; De Marinis, F.; Eberhardt, Wilfried; Paz-Ares, L. G.; Schumacher, K.; Gatzemeier, U.; Pirker, R.
    First-cycle rash as a clinical marker in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line chemotherapy (CT) plus cetuximab : Efficacy by histology
    In: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. Suppl. 15, S. 7556
  • Debus, Jürgen; Eberhardt, Wilfried; Hoffmann, Hans; Passlick, Bernward; Rübe, Christian; Thomas, Michael
    Grenzlinien der Kuration
    In: Oncology Research and Treatment Jg. 33 (2010) Nr. Suppl. 5, S. 12 - 20
  • Pöttgen, Christoph; Eberhardt, Wilfried; Gauler, Thomas; Krbek, Thomas; Berkovic, Katharina; Abu Jawad, Jehad; Korfee, Sönke; Teschler, Helmut; Stamatis, Georgios; Stuschke, Martin
    Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 76 (2010) Nr. 3, S. 809 - 815
  • Weder, Walter; Collaud, Stéphane; Eberhardt, Wilfried; Hillinger, Sven; Welter, Stefan; Stahel, Rolf; Stamatis, Georgios
    Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer
    In: The Thoracic and Cardiovascular Surgeon Jg. 139 (2010) Nr. 6, S. 1424 - 1430
  • Schütt, Philipp; Schütt, Birgit; Switala, Magdalena; Bauer, Sebastian; Stamatis, Georgios; Opalka, Bertram; Eberhardt, Wilfried; Schuler, Martin; Horn, Peter; Rebmann, Vera
    Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients
    In: Human Immunology Jg. 71 (2010) Nr. 5, S. 489 - 495
  • Goeckenjan, Gerd; Sitter, Helmut; Thomas, Michael Byrne; Branscheid, Detlev; Flentje, Michael P.; Griesinger, Frank; Niederle, Norbert; Stuschke, Martin; Blum, Torsten G.; Deppermann, Karl Matthias; Ficker, Joachim H.; Freitag, Lutz; Lübbe, Andreas Stephan; Reinhold, Thomas; Späth-Schwalbe, Ernst; Ukena, Dieter; Wickert, M.; Wolf, Martin; Andreas, Stefan; Auberger, Thomas; Baum, Richard P.; Baysal, B.; Beuth, Joseph; Bickeböller, Heike; Böcking, Alfred H.; Bohle, Rainer Maria; Brüske, Irene; Burghuber, Otto C.; Dickgreber, Nicolas J.; Diederich, Stefan; Dienemann, Hendrik C.; Eberhardt, Wilfried; Eggeling, Stephan; Fink, Thomas H.; Fischer, Berthold M.; Franke, M.; Friedel, Godehard; Gauler, Thomas; Gütz, Sylvia; Hautmann, Hubert; Hellmann, Andreas; Hellwig, Dirk; Herth, Felix J.F.; Heußel, Claus Peter; Hilbe, Wolfgang; Hoffmeyer, Frank; Horneber, Markus A.; Huber, Rudolf Maria; Hübner, Jutta; Kauczor, Hans Ulrich; Kirchbacher, Klaus; Kirsten, Detlef K.; Kraus, Thomas; Lang, Susanne M.; Martens, Uwe M.; Mohn-Staudner, Andrea; Müller, Klaus Michael; Müller-Nordhorn, Jacqueline; Nowak, Dennis A.; Ochmann, Uta; Passlick, Bernward; Petersen, Iver; Pirker, Robert A.; Pokrajac, Boris; Reck, Martin; Riha, Susanne; Rübe, Christian E.; Schmittel, Alexander; Schönfeld, Nicolas; Schütte, Wolfgang; Serke, Monika; Stamatis, Georgios; Steingräber, Maria; Steins, Martin B.; Stoelben, Erich; Swoboda, Lothar; Teschler, Helmut; Tessen, Hans Werner; Weber, Martin R.; Werner, Andreas; Wichmann, Heinz-Erich; Irlinger Wimmer, E.; Witt, Christian; Worth, Heinrich
    Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms
    In: Pneumologie Jg. 64 (2010) Nr. Suppl. 2, S. e1 - e164
  • Hoffmann, Andreas-Claudius; Gauler, Thomas; Parr, A.; Eberhardt, Wilfried; Schuler, Martin
    Use of ERCC1 expression levels in circulating tumor cells to predict to response to platinum-based chemotherapy in patients with non-small cell lung cancer
    In: Journal of Clinical Oncology (JCO) Jg. 28 S (2010) Nr. 15, S. Abstract7512
  • O'Byrne, K.; Eberhardt, Wilfried; Storkel, S.; Schumacher, K.; Heeger, S.; Stroh, C.; Celik, I.; von Heydebreck, A.; Pirker, R.
    Use of a Continuous EGFR IHC Scoring Method Reveals Association between Tumor Response and ECFR Expression Levels for Patients Receiving Cetuximab plus CT versus CT Alone in the Phase III Trial FLEX in Advanced NSCLC
    In: Journal of Thoracic Oncology Jg. 5 (2010) Nr. 12 Suppl. 7, S. S558 - S559
  • Herbst, Roy S.; Sun, Yan; Eberhardt, Wilfried; Germonpré, Paul R.; Saijo, Nagahiro; Zhou, Caicun; Wang, Jiejun; Li, Longyun; Kabbinavar, Fairooz F.; Ichinose, Yukito; Qin, Shukui; Zhang, Li; Biesma, Bonne; Heymach, John V.; Langmuir, Peter B.; Kennedy, Sarah J.; Tada, Hirohito; Johnson, Bruce E.
    Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC) : a double-blind, randomised, phase 3 trial
    In: The Lancet Oncology Jg. 11 (2010) Nr. 7, S. 619 - 626
  • Pöttgen, Christoph; Theegarten, Dirk; Eberhardt, Wilfried; Levegrün, Sabine; Gauler, Thomas; Krbek, Thomas; Stamatis, Georgios; Teschler, Helmut; Kuehl, Hilmar; Bockisch, Andreas; Stuschke, Martin
    Correlation of PET/CT findings and histopathology after neoadjuvant therapy in non-small cell lung cancer
    In: Oncology Jg. 73 (2008) Nr. 5-6, S. 316 - 323
  • Marra, Alex; Eberhardt, Wilfried; Pöttgen, Christoph; Theegarten, Dirk; Korfee, Sönke; Gauler, Thomas; Stuschke, Martin; Stamatis, Georgios
    Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour
    In: European Respiratory Journal Jg. 29 (2007) Nr. 1, S. 117 - 127
  • Pöttgen, Christoph; Levegrün, Sabine; Theegarten, Dirk; Marnitz, Simone; Grehl, Sara; Pink, Roman; Eberhardt, Wilfried; Stamatis, Georgios; Gauler, Thomas; Antoch, Gerald; Bockisch, Andreas; Stuschke, Martin
    Value of ¹⁸F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy
    In: Clinical Cancer Research Jg. 12 (2006) Nr. 1, S. 97 - 106
  • Vorworte / Nachworte

  • Sebastian, Martin; Stratmann, Jan Alexander; Eberhardt, Wilfried
    Too Good to be True?
    In: Journal of Thoracic Oncology Jg. 16 (2021) Nr. 4, S. 507 - 508
  • Eberhardt, Wilfried
    How should we choose the best therapy for elderly patients with stage III non-small-cell lung cancer?
    In: Journal of Clinical Oncology (JCO) Jg. 35 (2017) Nr. 25, S. 2860 - 2862
  • Eberhardt, Wilfried; Hepp, R.
    Staging of the Mediastinum : Are We Already There?
    In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. 9, S. 1114 - 1115
  • Eberhardt, Wilfried
    Compassionate use programs or phase IV trials of innovative molecular targeted drugs in lung cancer: Deal or no deal?
    In: Journal of Thoracic Oncology Jg. 5 (2010) Nr. 10, S. 1495 - 1497
  • Abstracts

  • Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Özkan, Filiz; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Hamacher, Rainer; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, H.
    68Ga-SSO-120 versus 18F-FDG PET in the Initial Staging of Small-Cell Lung Cancer Patients
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. Suppl. 1, Annual Congress of the European Association of Nuclear Medicine September 9–13, 2023 Vienna, Austria, S. 488 - S489
  • Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Oezkan, Filiz; Bolukbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, Hubertus
    68Ga-Satoreotide PET for Staging of Small-Cell Lung Cancer Patients
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P165
  • Richlitzki, Cedric; Pöttgen, Christoph; Wiesweg, Marcel; Metzenmacher, Martin; Guberina, Nika; Gauler, Thomas; Hautzel, Hubertus; Eberhardt, Wilfried; Darwiche, Kaid; Theegarten, Dirk; Bölükbas, Servet; Schuler, Martin; Stuschke, Martin; Guberina, Maja
    Kreuzvalidierte Prognoseparameter C-reaktives Protein und Blutbild-Parameter im Verlauf der kurativ intendierten Radiochemotherapie bei Patienten mit nichtkleinzelligem Lungenkarzinom (NSCLC) im Stadium IIIA-C
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S100 - S101
  • Fischedick, Gerrit; Sahin, Ezgi Ceren; Lübcke, Wolfgang; Gauler, Thomas; Guberina, Maja; Guberina, Nika; Ahmadipour, Yahya; Garcia, Alina Santiago; Zimmer, Lisa; Hense, Jörg; Eberhardt, Wilfried; Stuschke, Martin; Pöttgen, Christoph
    Langzeitergebnisse nach hypofraktionierter ablativer Präzisionsbestrahlung bei Patienten mit multiplen cerebralen Metastasen
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S124
  • Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Cordes, Sebastian; Metzenmacher, Martin; Brintrup, Diana Luetke; Guberina, Maja; Filiz, Özkan; Darwiche, Kaid; Schuler, Martin; Jöckel, Karl-Heinz; Aigner, Clemens; Stamatis, Georgios; Eberhardt, Wilfried
    Langzeitüberleben und konkurrierende Risiken von Patienten einer randomisierten Studie zur defnitiven vs. neoadjuvanten Radiochemotherapie + Resektion mit einem nach der Induktion resektablen NSCLC im Stadium III
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S7 - S8
  • Wiesweg, Marcel; Küter, C.; Schnorbach, J.; Keyl, J.; Plönes, T.; Metzenmacher, M.; Cvetkovic, J.; Eberhardt, Wilfried E.E.; Oezkan, F.; Theegarten, Dirk; Stenzinger, A.; Darwiche, Kaid; Herth, F.J.F.; Bölükbas, S.; Winter, H.; Weykamp, F.; Stuschke, Martin; Thomas, M.; Schuler, Martin H. H.; Christopoulos, P.;
    Oligometastatic non-small cell lung cancer : Impact of local and systemic treatment approaches on clinical outcome
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S828
  • Gauler, Thomas; Eberhardt, Wilfried; Martin, Sebastian
    PCI in der metastasierten Situation beim SCLC in real world : Daten aus der Clinical Research platform Into molecular testing, treatment and outcome of (non-)Small cell lung carcinoma Patients (CRISP; AIO-TRK-0315)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S97
  • Stuschke, Martin; Griesinger, Frank; Eberhardt, Wilfried
    Real-world Daten zur Erhaltungstherapie mit Durvalumab nach defnitiver Strahlenchemotherapie bei Patienten mit Nicht-Kleinzelligem Lungenkarzinom in lokal fortgeschrittenen Stadien : Daten aus der Clinical Research platform Into molecular testing, treatment and outcome of (non-)Small cell lung carcinoma Patients (CRISP; AIO-TRK-0315)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S103
  • Eberhardt, Wilfried E. E.; Thomas, M.; Stuschke, Martin; Griesinger, F.; et al.;
    Testing for and frequency of EGFR and ALK alterations in patients with early and locally advanced non-small cell lung cancer in Germany : Results from the prospective German Registry CRISP (AIO-TRK-0315)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 10 - 11
  • Lanzafame, H.; Hirmas, N.; Schuler, Martin; Darwiche, Kaid; Eberhardt, Wilfried E. E.; Aigner, Clemens; Stuschke, Martin; Kessler, Lukas; Pabst, K. M.; Barbato, F.; Rischpler, Christoph; Hautzel, H.; Herrmann, Ken; Fendler, Wolfgang;
    68GA-FAPI PET/CT in the evaluation of Non-Small Cell Lung Cancer (NSCLC)
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S107
  • Eberhardt, Wilfried; Passlick, B.; Stuschke, Martin; Groeschel, A.; Christopoulos, P.; Reck, M.; Ludwig, P.; Hipper, A.; Chiabudini, M.; Spring, L.; Jänicke, M.; Andres-Pons, A.; Christoph, D.C.; Bernhardt, C.; Reiser, M.; Sebastian, M.; Griesinger, F.; Thomas, M.;
    Clinical research platform Into molecular testing, treatment and outcome of non-Small cell lung carcinoma Patients (CRISP) : Real-world evidence of NSCLC patients treated with radiochemotherapy in Germany – AIO-TRK-0315
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France and virtual,
    In: Annals of Oncology Jg. 33 (2022) Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S988
  • Griesinger, F.; Sebastian, M.; Bethge, A.; Christopoulos, P.; Hoffknecht, P.; Waller, C.; Benkelmann, R.; Jänicke, M.; Fleitz, A.; Hanselmann, J.; Hipper, A.; Groth, A.; Weichert, W.; Nusch, A.; Rauh, J.; Fietz, T.; Illmer, T.; Depenbusch, R.; Eberhardt, Wilfried; Thomas, M.
    EGFR exon 20 insertion mutations in patients with locally advanced or metastatic NSCLC in the German prospective, CRISP Registry real-world cohort (AIO-TRK-0315)
    In: Annals of Oncology Jg. 33 (2022) Nr. Suppl. 2, S. 54 - S55
  • Jehn, B. L.; Waelscher, J.; Wessendorf, Thomas; Livingstone, Elisabeth; Zimmer, Lisa; Metzenmacher, M.; Eberhardt, Wilfried; Theegarten, Dirk; Taube, Christian; Bonella, Francesco;
    Immune Checkpoint Inhibitor (ICI)-associated Pulmonary Manifestations (ICI-LM): Characterization of HRCT and BAL Findings
    62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.; 25.–28.05.2022; Leipzig,
    In: Pneumologie Jg. 76 (2022) Nr. Supplement 1, S. S52
  • Eberhardt, Wilfried; Passlick, B.; Stuschke, Martin; Gröschel, A.; Christopoulos, P.; Reck, M.; Ludwig, P.; Hipper, A.; Chiabudini, M.; Spring, L.; Jänicke, M.; Andres-Pons, A.; Christoph, D. C.; Bernhardt, C.; Reiser, M.; Sebastian, M.; Griesinger, F.; Thomas, M.;
    Klinische Plattform zur Erforschung molekularer Testung, Behandlung und Krankheitsverlauf von Patienten mit Lungenkrebs (CRISP) : Real-World Evidence zu NSCLC Patienten behandelt mit Radiochemotherapie in Deutschland - AIO-TRK-0315
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 269 - 270
  • Eberhardt, Wilfried; Pöttgen, Christoph; Gauler, Thomas; Schulte, C; Friedel, G.; Kopp, H.-G.; Fischer, B.; Schmidberger, H.; Kimmich, M.; Budach, W.; Cordes, S.; Metzenmacher, M.; de Los Rios, R. Hepp; Spengler, W.; De Ruysscher, D.; Belka, C.; Welter, S.; Brintrup, D. Luetke; Guberina, M.; Oezkan, F.; Darwiche, Kaid; Schuler, Martin; Jöckel, Karl-Heinz; Aigner, Clemens; Stamatis, Georgios; Stuschke, Martin
    Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLC
    In: Journal of Thoracic Oncology Jg. 17 (2022) Nr. 9, S. 65
  • Sebastian, M.; Griesinger, F.; von der Heyde, E.; Dörfel, S.; Wiegand, J.; Schiefer, C.; Losem, C.; Jänicke, M.; Fleitz, A.; Zacharias, S.; Hipper, A.; Dietel, C.; Bleckmann, A.; Benkelmann, R.; Boesche, M.; Grah, C.; Müller, A.; Eberhardt, Wilfried E. E.; Thomas, M.; ; CRISP Registry Group
    Patient-reported outcomes vor und während der COVID-19-Pandemie bei Patienten mit lokal fortgeschrittenem oder metastasiertem nicht-kleinzelligen Lungenkarzinom in Deutschland : Daten aus der prospektiven CRISP Registerplattform (AIO-TRK-0315)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 127
  • Guberina, M.; Pöttgen, Christoph; Guberina, N.; Gauler, Thomas; Metzenmacher, M.; Wiesweg, Marcel; Richlitzki, C.; Plönes, T.; Forsting, Michael; Wetter, Axel; Herrmann, Ken; Hautzel, H.; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Eberhardt, Wilfried E. E.; Stuschke, Martin;
    Robuste und lang-andauernde Wirksamkeit der Durvalumab-Konsolidierung bei NSCLC im Stadium III nach Induktionschemotherapie und definitiver Radiochemotherapie : Fokus auf Behandlungsauswahl und prognostische Faktoren
    28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 198 (2022) Nr. Supplement 1, S. S15
  • Jehn, Lutz-Bernhard; Wälscher, Julia; Wessendorf, Thomas; Livingstone, Elisabeth; Zimmer, Lisa; Metzenmacher, Martin; Eberhardt, Wilfried; Theegarten, Dirk; Bonella, Francesco
    Bronchoalveolar lavage fluid (BALF) findings in patients with immune checkpoint inhibitor (ICI)-associated interstitial pneumonia (IP)
    In: European Respiratory Journal (ERJ) (2021) OA4240
  • Griesinger, F.; Sebastian, M.; Brückl, W.; Hummel, H.-D.; Jaeschke, B.; Kern, J.; Schumann, C.; Wesseler, C.; Jänicke, M.; Fleitz, A.; Zacharias, S.; Hipper, A.; Groth, A.; Weichert, W.; Dörfel, S.; Petersen, V.; Schröder, J.; Wilke, J.; Eberhardt, Wilfried E. E.; Thomas, M.; ; CRISP Registry Group
    Checkpoint inhibitor monotherapy in potentially study-eligible or non-study-eligible NSCLC patients in the German CRISP Registry real-world cohort (AIO-TRK-0315)
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 111
  • Griesinger, Frank; Sebastian, Martin; Brückl, Wolfgang M.; Hummel, Horst Dieter; Jaeschke, B.; Kern, J.; Schumann, Christian; Wesseler, Claas; Jänicke, M.; Fleitz, A.; Zacharias, Stefan; Hipper, Annette; Groth, Anne; Weichert, Wilko; Dörfel, Steffen; Petersen, Volker; Schröder, Jan Klaus; Wilke, Jochen; Eberhardt, Wilfried; Thomas, Michael
    Checkpoint inhibitor monotherapy in potentially study-eligible or non-study-eligible NSCLC patients in the German CRISP registry real-world cohort (AIO-TRK-0315)
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. S1015 - S1016
  • Stuschke, Martin; Passlick, B.; Groeschel, A.; Christopoulos, P.; Reck, M.; Grah, C.; Groth, A.; Hipper, A.; Chiabudini, M.; Fleitz, A.; Jaenicke, M.; Spring, L.; Christoph, Daniel; Bernhardt, C.; Thomas, M.; Eberhardt, Wilfried
    Clinical Platform for Research into molecular Testing, Treatment and Disease Progression in Patients with Lung Cancer (CRISP) : First Real-World Evidence on Stage II and III NSCLC in Germany - AIO-TRK-0315
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. S11 - S12
  • Eberhardt, Wilfried E. E.; Passlick, B.; Stuschke, Martin; Gröschel, A.; Christopoulos, P.; Reck, M.; Grah, C.; Groth, A.; Hipper, A.; Chiabudini, M.; Fleitz, A.; Jänicke, M.; Spring, L.; Christoph, D. C.; Bernhardt, C.; Reiser, M.; Zahn, M.-O.; Sebastian, M.; Griesinger, F.; Thomas, M.; CRISP Registry Group;
    Clinical research platform Into molecular testing, treatment and outcome of non-Small cell lung carcinoma patients (CRISP) : First real-world evidence of NSCLC Stage II and III in Germany - AIO-TRK-0315
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 3
  • Gröschel, A.; Passlick, B.; Stuschke, Martin; Christopoulos, P.; Reck, M.; Grah, C.; Groth, A.; Hipper, A.; Chiabudini, M.; Fleitz, A.; Jänicke, M.; Spring, L.; Christoph, Daniel; Bernhardt, C.; Reiser, M.; Zahn, M-O.; Sebastian, M.; Griesinger, F.; Thomas, M.; Eberhardt, Wilfried
    Clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma patients (CRISP) : First real-world evidence of NSCLC stage II and III in Germany - AIO-TRK-0315
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. S935 - S936
  • Christoph, Daniel; Ferdinandus, Justin; Metzenmacher, Martin; Kessler, Peter; Umutlu, Lale; Aigner, Clemens; Kambartel, Karl-Otto; Grünwald, Viktor; Eberhardt, Wilfried; Fendler, Wolfgang; Herrmann, Ken; Faehling, Martin
    Complete metabolic response in advanced non-small cell lung cancer patients with prolonged response to immune checkpoint inhibitor therapy
    In: Journal of Clinical Oncology Jg. 39 (2021) Nr. 15_Suppl, S. 9050 - 9050
  • Guberina, M.; Herrmann, Ken; Pöttgen, Christoph; Guberina, N.; Hoffmann, C.; Ploenes, T.; Gauler, Thomas; Wetter, Axel; Umutlu, Lale; Hautzel, H.; Theegarten, Dirk; Schuler, Martin; Eberhardt, Wilfried; Metzenmacher, M.; Wiesweg, Marcel; Aigner, Clemens; Darwiche, Kaid; Karpf-Wissel, Rüdiger; Stuschke, Martin
    EBUS-TBNA and [F-18] FDG-PET/CT for precise Target Volume Definition prior to Chemoradiotherapy : Lymphonodular Spreading Patterns in Stage III NSCLC
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 142
  • Fischedick, G.; Pöttgen, Christoph; Lübcke, Wolfgang; Gauler, Thomas; Guberina, M.; Guberina, N.; Pierscianek, D.; Livingstone, Elisabeth; Hense, Jörg; Eberhardt, Wilfried; Stuschke, Martin
    Image-guided ablative Radiotherapy for Patients with multiple cerebral Metastases using Precision helical Irradiation
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 183
  • Pöttgen, Christoph; Gauler, Thomas; Guberina, M.; Pierscianek, D.; Wrede, Karsten; Wiesweg, Marcel; Eberhardt, Wilfried; Schuler, Martin; Stuschke, Martin
    Re-Irradiation of cerebral Metastases after prophylactic Brain Skull irradiation in small-cell neuroendocrine Lung Cancer (SCLC)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 176
  • Chan, M.; Guberina, Marko; Stuschke, Martin; Pöttgen, Christoph; Aigner, Clemens; Eberhardt, Wilfried; Hautzel, Hubertus; Guberina, Nika;
    Evaluation der Korrelation des anatomischen und funktionellen CT-Ventilations- und SPECT-Perfusions-Lungenvolumens bei Patienten mit Nicht-kleinzelligem Lungenkarzinom
    26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 196 (2020) Nr. 1 Supplement: Abstracts DEGRO 2020, S. S145 - S146
  • Griesinger, Frank; Sebastian, M.; Fleitz, Annette; Hipper, Annette; Buller, M.; Jaenicke, Martina; Eberhardt, Wilfried; Thomas, Michael;
    How does the SarsCov2 epidemic the treatment of patients with lung cancer in Germany? : Data from the prospective CRISP registry
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 137
  • Guberina, Marko; Pöttgen, Christoph; Guberina, Nika; Hautzel, Hubertus; Herrmann, Ken; Theegarten, Dirk; Aigner, Clemens; Plones, Till; Gauler, Thomas; Eberhardt, Wilfried; Schuler, Martin; Karpf-Wissel, Rüdiger; Darwiche, Kaid; Stuschke, Martin;
    Lymphknoten-Staging von lokal fortgeschrittenen, nicht kleinzelligen Lungenkarzinomen (NSCLC) : Wert von [18F] FDG-PET/CT und EBUS/TBNA zur Festlegung des Zielvolumens bei definitiver Radiotherapie in kurativer Intention
    26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 196 (2020) Nr. 1 Supplement: Abstracts DEGRO 2020, S. S143
  • Pöttgen, Christoph; Plajer, D.; Gauler, Thomas; Guberina, Marko; Santiago, Alina; Guberina, Nika; Eberhardt, Wilfried; Schuler, Martin; Darwiche, Kaid; Plönes, Till; Aigner, Clemens; Stuschke, Martin;
    Optimierung prognostischer Modelle für das Überleben von Patienten mit lokal fortgeschrittenen kleinzelligen Lungenkarzinomen nach definitiver Radiochemotherapie mittels künstlicher Intelligenz
    26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 196 (2020) Nr. 1 Supplement: Abstracts DEGRO 2020, S. S57 - S58
  • Kraskowski, O.; Eberhardt, Wilfried; Metzenmacher, Martin; Zaun, Gregor; McCutcheon, A.; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Darwiche, Kaid; Aigner, Clemens; Kasper, Stefan; Hense, Jörg; Gruenwald, Viktor; Wiesweg, Marcel; Schuler, Martin; Pogorzelski, Michael;
    Patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC) show highly favorable outcomes with treatment sequences provided at a comprehensive cancer center
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 137
  • Sebastian, M.; Eberhardt, Wilfried; Losem, C.; Bernhardt, C.; Maintz, C.; Marschner, N.; Jaenicke, M.; Fleitz, A.; Spring, L.; Sahlmann, J.; Karatas, A.; Hipper, A.; Weichert, W.; Hoffknecht, P.; Grah, C.; Rittmeyer, A.; Griesinger, F.; Thomas, M.;
    Patients with metastatic non-small cell lung cancer and PD-L1 expression in Germany : Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315)
    61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.; 25.–28. März 2020 (verschoben auf 2021), Leipzig,
    In: Pneumologie Jg. 74 (2020) Nr. Suppl. 1, S. S127
  • Griesinger, F.; Eberhardt, Wilfried; Nusch, A.; Reiser, M.; Zahn, M.O.; Marschner, N.; Jaenicke, M.; Fleitz, A.; Spring, L.; Sahlmann, J.; Karatas, A.; Hipper, A.; Weichert, W.; Waller, C.; Reck, M.; Christopoulos, P.; Sebastian, M.; Thomas, M.;
    Patients with metastatic non-small cell lung cancer and targetable molecular alterations in Germany : Treatment and first outcome data from the prospective German Registry Platform CRISP (AIO-TRK-0315)
    61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.; 25.–28. März 2020 (verschoben auf 2021), Leipzig,
    In: Pneumologie Jg. 74 (2020) Nr. Suppl. 1, S. S132
  • Griesinger, F.; Eberhardt, Wilfried; Bruch, H.R.; Rauh, J.; von der Heyde, E.; Marschner, N.; Jaenicke, M.; Fleitz, A.; Spring, L.; Sahlmann, J.; Karatas, A.; Hipper, A.; Weichert, W.; Sadjadian, P.; Metzenmacher, M.; Gleiber, W.; Sebastian, M.; Thomas, M.;
    Patients with metastatic non-small cell lung cancer without molecular alterations or PD-L1 expression in Germany : Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315)
    61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.; 25.–28. März 2020 (verschoben auf 2021), Leipzig,
    In: Pneumologie Jg. 74 (2020) Nr. Suppl. 1, S. S15 - S16
  • Griesinger, F.; Eberhardt, Wilfried; Hoffknecht, P.; Metzenmacher, Martin; Wehler, T.; Kokowski, K.; Alt, J.; Schütte, W.; Jänicke, M.; Fleitz, A.; Zacharias, S.; Hipper, A.; Buller, M.; Weichert, W.; Groschek, M.; Heyde, E. von der; Rauh, J.; Dechow, T.; Sebastian, M.; Thomas, M.;
    Treatment and outcome of a real-world cohort of patients with advanced, non-squamous NSCLC and KRAS mutations with a special focus on KRAS G12C
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 135
  • Griesinger, F.; Eberhardt, Wilfried; Hoffknecht, Petra; Metzenmacher, Martin; Wehler, T.; Kokowski, K.; Alt, Jürgen; Schütte, Wolfgang; Jänicke, Martina; Fleitz, Annette; Zacharias, Steffen; Hipper, A.; Buller, M.; Weichert, Wilko; Groschek, M.; Heyde, E. von der; Rauh, J.; Dechow, T.; Sebastian, M.; Thomas, M.;
    Treatment and outcome of a real-world cohort of patients with advanced, non-squamous NSCLC and KRAS mutations with a special focus on KRAS G12C
    ESMO Virtual Congress 2020, 19 – 21 September / 16 – 18 October 2020,
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S872
  • Guberina, Nika; Pöttgen, Christoph; Sahin, Zumrut; Aigner, Clemens; Eberhardt, Wilfried; Guberina, Marko; Indenkämpen, Frank; Stuschke, Martin;
    Welche Standard-PTV-Säume werden bei gegateter Strahlentherapie in Exspiration bei lokal fortgeschrittenen Lungenkarzinomen nach online-Navigation benötigt?
    26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 196 (2020) Nr. 1 Supplement: Abstracts DEGRO 2020, S. S58
  • Borchert, S.; Wessolly, M.; Schmeller, J.; Mairinger, E.; Kollmeier, J.; Hager, T.; Mairinger, T.; Herold, T.; Christoph, Daniel; Walter, R.; Eberhardt, Wilfried; Plönes, T.; Wohlschläger, Jeremias; Aigner, Clemens; Schmid, K.; Mairinger, F.
    Defects in Homologous Recombination Repair Indicates Susceptibility for Olaparib Treatment in Malignant Pleural Mesothelioma
    In: Journal of Thoracic Oncology Jg. 14 (2019) Nr. 10, Supplement, S. S482
  • Schmeller, Jan; Mairinger, Fabian; Wessolly, Michael; Mairinger, Elena; Borchert, Sabrina; Kollmeier, Jens; Hager, Thomas; Mairinger, Thomas; Christoph, Daniel; Walter, Robert; Eberhardt, Wilfried; Plönes, Till; Wohlschläger, Jeremias; Jasani, Bharat; Schmid, Kurt Werner; Bankfalvi, Agnes;
    Immunohistochemically Detectable Metallothionein Expression in Malignant Pleural Mesotheliomas is Strongly Associated with Early Failure to Platin-Based Chemotherapy
    Herbsttagung der Sektion Zellbiologie in der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., Essen, 09.–10.11.2018,
    In: Pneumologie Jg. 73 (2019) Nr. 02, S. 110 - 111
  • Hegedüs, Balasz; Wohlschläger, Jeremias; Wessolly, Michael; Hager, Thomas; Mairinger, Elena; Suckrau, Pia; Eberhardt, Wilfried; Mairinger, Fabian; Schmeller, Jan; Herold, Thomas; Schmid, Kurt Werner; Aigner, Clemens; Borchert, Sabrina; Bankfalvi, Agnes; Walter, Robert;
    Influence of Methallothionein Expression on Sensitivity Against Platin Compounds in Human Malignant Pleural Mesothelioma Cell Lines – Knock-Down of Gene Expression as New Therapeutic Approach?
    Herbsttagung der Sektion Zellbiologie in der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., Essen, 09.–10.11.2018,
    In: Pneumologie Jg. 73 (2019) Nr. 02, S. 115
  • Sebastian, M.; Eberhardt, Wilfried; Losem, C.; Bernhardt, C.; Maintz, C.; Marschner, N.; Jänicke, M.; Fleitz, A.; Spring, L.; Sahlmann, J.; Karatas, A.; Hipper, A.; Weichert, W.; Hoffknecht, P.; Grah, C.; Rittmeyer, A.; Griesinger, F.; Thomas, M.;
    Patients with metastatic non-small cell lung cancer and PD-L1 expression in Germany : treatment and first outcome from the prospective German registry platform CRISP (AIO-TRK-0315)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,
    In: Oncology Research and Treatment Jg. 42 (2019) Nr. Supplement 4: Abstracts, S. 113
  • Griesinger, F.; Eberhardt, Wilfried; Bruch, H.-R.; Rauh, J.; Heyde, E. von der; Marschner, N.; Jänicke, M.; Fleitz, A.; Spring, L.; Sahlmann, J.; Karatas, A.; Hipper, A.; Weichert, W.; Sadjadian, P.; Metzenmacher, M.; Gleiber, W.; Sebastian, M.; Thomas, M.;
    Patients with metastatic non-small cell lung cancer without molecular alterations or PD-L1 expression in Germany : Treatment and first outcome from the prospective German registry platform CRISP (AIO-TRK-0315)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,
    In: Oncology Research and Treatment Jg. 42 (2019) Nr. Supplement 4: Abstracts, S. 109
  • Griesinger, F.; Eberhardt, Wilfried; Nusch, A.; Reiser, M.; Zahn, M.-O.; Marschner, N.; Jänicke, M.; Fleitz, A.; Spring, L.; Sahlmann, J.; Karatas, A.; Hipper, A.; Weichert, W.; Waller, C. F.; Reck, M.; Christopoulos, P.; Sebastian, M.; Thomas, M.;
    Patients with metastatic non-small cell lung carcinoma and targetable oncogenic molecular alterations in Germany : Treatment and first outcome data from the prospective German registry CRISP (AIO-TRK-0315)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,
    In: Oncology Research and Treatment Jg. 42 (2019) Nr. Supplement 4: Abstracts, S. 107
  • Plones, T.; Schmeller, J.; Christoph, Daniel; Walter, R.; Hager, T.; Schmid, Kurt Werner; Borchert, S.; Bankfalvi, Agnes; Mairinger, T.; Mairinger, E.; Mairinger, F.; Wohlschlager, J.; Eberhardt, Wilfried; Wessolly, M.; Kollmeier;
    Processing Escapes : an Alternative Explanation for Immune Therapy Resistance
    Herbsttagung der Sektion Zellbiologie in der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., Essen, 09.–10.11.2018,
    In: Pneumologie Jg. 73 (2019) Nr. 02, S. 111 - 112
  • Wessolly, M.; Streubel, A.; Werner, R.; Borchert, S.; Stephan-Falkenau, S.; Griff, S.; Mairinger, E.; Schmeller, J.; Walter, R.; Bauer, T.; Eberhardt, Wilfried; Blum, T.; Schmid, Kurt Werner; Kollmeier, J.; Mairinger, F.; Mairinger, T.
    Processing Escapes : Novel Resistance Mechanisms Under Immune Checkpoint Inhibition in NSCLC
    In: Journal of Thoracic Oncology Jg. 14 (2019) Nr. 10, Supplement, S. S450
  • Guberina, M.; Stuschke, Martin; Eberhardt, Wilfried; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Dirk, T.; Jentzen, Walter; Herrmann, Ken; Pöttgen, Christoph;
    Prognostic Value of Metabolic Tumor Volume after Induction Chemotherapy in Stage IIIA/B Non-Small-Cell Lung Cancer : Secondary Analysis of a Randomized Phase 3 Trial
    61st Annual Meeting of the American Society for Radiation Oncology ; September 15-18, 2019, Chicago, IL, USA,
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 105 (2019) Nr. 1, Supplement, S. S146 - S147
  • Bogner, Simon; Schmid, Kurt Werner; Metzenmacher, Martin; Hager, Thomas; Herrmann, Ken; Walter, Robert; Hegedues, Balazs; Herold, Thomas; Eberhardt, Wilfried; Reis, Henning; Goetz, Moritz; Mairinger, Fabian Dominik; Wiesweg, Marcel; Darwiche, Kaid; Aigner, Clemens; Schuler, Martin
    Development of predictors for PD-1/PD-L1-directed therapy of non-small cell lung cancer (NSCLC) by gene expression profiling of small diagnostic biopsies (DBX)
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 15 Suppl., S. e15121
  • Exner, J.-P.; Nadjm, S.; Gauler, Thomas; Pöttgen, Christoph; Krebs, B.; Cheufou, D.; Darwiche, Kaid; Metzenmacher, M.; Theegarten, Dirk; Umutlu, Lale; Hoffmann, Andreas-Claudius; Oezkan, F.; Aigner, Clemens; Taube, Christian; Schuler, Martin; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried;
    Long-term Survival (LT-S) and Survivorship Program (SS-P) of Lung Cancer (LC) Patients (Pts) - B : Implications for Follow-up (F-up) and Surveillance (SV)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 109 - 110
  • Nadjm, S.; Exner, J. P.; Gauler, Thomas; Pöttgen, Christoph; Darwiche, Kaid; Cheufou, D.; Krebs, B.; Metzenmacher, M.; Oezkan, F.; Rebmann, Vera; Umutlu, Lale; Deuschl, C.; Li, Y.; Lahner, Harald; Christoph, Daniel; Hoiczyk, M.; Witzke, Oliver; Hoffmann, Andreas-Claudius; Aigner, Clemens; Theegarten, Dirk; Taube, Christian; Schuler, Martin; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried;
    Long-term Survival(LTS) and Survivorship Program(SS-P) of Lung Cancer(LC) Patients(Pts). Investigations(Invest) on LT-toxicities(Tox) and late morbidities(Morb)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 108
  • Griesinger, F.; Eberhardt, Wilfried; Nusch, A.; Reiser, M.; Losem, C.; Ketzler-Henkel, S.; Zahn, M.-O.; Marschner, N.; Jänicke, M.; Fleitz, A.; Spring, L.; Karatas, A.; Hipper, A.; de Wit, M.; Metzenmacher, M.; Waller, C.; Kern, J.; Weichert, W.; Sebastian, M.; Thomas, M.;
    Molecular testing, frequency of molecular alterations and first-line treatment of patients with non-small cell lung carcinoma (NSCLC) in Germany : First results from the prospective German Registry CRISP (AIO-TRK-0315)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 17 - 17
  • Griesinger, Frank; Eberhardt, Wilfried; Nusch, Arnd; Reiser, Marcel; Zahn, Mark-Oliver; Marschner, Norbert Walter; Jänicke, Martina; Fleitz, Annette; Spring, Lisa; Sahlmann, Joerg; Karatas, Aysun; Hipper, Annette; Weichert, Wilko; Rittmeyer, Achim; Metzenmacher, Martin; Waller, Cornelius F.; Sebastian, Martin; Thomas, Michael
    Molecular testing, frequency of molecular alterations and targeted 1st-line treatment of patients with non-small cell lung carcinoma in Germany : First results from the prospective German Registry CRISP (AIO-TRK-0315)
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. e21236 - e21236
  • Thomas, M.; Grohe, C.; Eberhardt, Wilfried; Rawluk, J.; Reck, M.; Laack, E.; Wesseler, C.; Rittmeyer, Achim; Alt, J.; Reinmuth, N.; Griesinger, F.; Kern, J.;
    POSEIDON : A phase 3 study of first-line Durvalumab +/- Tremelimumab plus chemotherapy vs chemotherapy alone in metastatic NSCLC
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; Wien, 28. September - 2. Oktober 2018,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 295
  • Griesinger, Frank; Eberhardt, Wilfried; Nusch, Arnd; Reiser, M.; Bernhardt, C.; Marschner, Norbert; Jaenicke, M.; Fleitz, Annette; Spring, Lisa; Sahlmann, Jörg; Karatas, A.; Hipper, A.; Weichert, Wilko; Rittmeyer, Achim; Bischoff, Helge G.; Waller, Cornelius F.; Thomas, Michael
    Testing for and frequency of molecular alterations in patients with advanced NSCLC in Germany : Results from the prospective German registry CRISP (AIO-TRK-0315)
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii515
  • Pöttgen, Christoph; Abu Jawad, Jehad; Indenkampen, F.; Heintz, Martin; Ebenau, M.; Wienczierz, M.; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin;
    Vergleich der 3D-Navigation der atemabhängigen Tumor-Position mittels stereoskopischer Röntgenaufnahmen (ExacTrac) bzw. kV-ConeBeam-CTs bei der kurativen Radiotherapie von Lungenkarzinomen
    23. Jahrestagung der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2017 ; 14. - 18. Juni 2017, Berlin, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 193 (2017) Nr. Suppl. 1: Abstracts DEGRO 2017, S. S79 - S80
  • Schütte, W.; Thomas, M.; Eberhardt, Wilfried; Zirrgiebel, U.; Radke, S.; Dietel, M.;
    Clinical Outcome of Targeted Therapy with Gefitinib in Metastatic NSCLC Depending on the Type of EGFR Mutation : A REASON Subgroup Analysis by Exon
    Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 120
  • Schütte, W.; Eberhardt, Wilfried; Schirmacher, P.; Dietel, M.; Zirrgiebel, U.; Radke, S.; Thomas, M.;
    REASON : Factors influencing outcome in patients (pts) with NSCLC stage IIIB/IV and mutated EGF receptor (EGFR-M plus ) treated with gefitinib
    Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 120
  • Guberina, M.; Stuschke, Martin; Abu Jawad, Jehad; Gauler, Thomas; Gkika, E.; Bockisch, Andreas; Stamatis, Georgios; Eberhardt, Wilfried; Pöttgen, Christoph;
    18 F-FDG-Response als prognostischer Faktor für das progressionsfreie Überleben bei der Behandlung von lokal fortgeschrittenen, nichtkleinzelligen Lungenkarzinonem : Trimodale Therapie vs. definitive Radiochemotherapie – Monozentrische Ergebnisse
    21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,
    In: Strahlentherapie und Onkologie Jg. 191 (2015) Nr. Suppl.1, S. S21 - S22
  • Pöttgen, Christoph; Levegrun, S.; Abu Jawad, Jehad; Lübcke, Wolfgang; Wittig, Andrea; Grehl, Sara; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin;
    Ganzhirnbestrahlung (WBRT) versus Ganzhirnbestrahlung mit bildgeführter stereotaktischer Bestrahlung multipler cerebraler Metastasen mittels helikaler Tomotherapie – Toxizitätsanalyse einer randomisierten Studie
    21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,
    In: Strahlentherapie und Onkologie Jg. 191 (2015) Nr. Suppl.1, S. 149
  • Pöttgen, Christoph; Stuschke, Martin; Gauler, Thomas; Welter, Stefan; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried;
    Hirnmetastasen bei Patienten mit lokal fortgeschrittenem NSCLC nach multimodaler kurativer Therapie in einem randomisierten Protokoll : prognostische Faktoren
    21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 191 (2015) Nr. Suppl. 1, S. 36 - 37
  • Joerger, M.; Salamone, S. J.; von Pawel, J.; Kraff, S.; Fischer, J. R.; Eberhardt, Wilfried; Gauler, Thomas; Muller, L.; Reinmuth, N.; Reck, M.; Kimmich, M.; Mayer, F.; Kopp, H. G.; Behringer, D. M.; Ko, Y. D.; Fruh, M.; Hilger, Ralf A.; Roessler, M.; Moritz, B.; Miller, Michael; Jaehde, U.;
    Randomized study of individualized, pharmacokinetically-guided dosing of paclitaxel combined with carboplatin in advanced non-small cell lung cancer patients
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,
    In: Oncology Research and Treatment Jg. 38 (2015) Nr. Suppl. 5, S. 14 - 14
  • Pöttgen, Christoph; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Jendrossek, Verena; Freitag, Lutz; Abu Jawad, Jehad; Gkika, E.; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, M.; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin;
    Rekursive Partitions-Analyse prognostischer Faktoren für das Langzeit-Überleben nach trimodaler Therapie von Patienten mit lokal fortgeschrittenem NSCLC
    21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 191 (2015) Nr. Suppl. 1, S. 23
  • Schumann, C.; Engel-Riedel, W.; Kollmeier, J.; Grohe, C.; von Pawel, J.; Eberhardt, Wilfried; Gutz, S.; Nimmrich, I.; Weiss, C.; Potzner, M.; Serke, M.; Thomas, M.;
    A multi-center phase II study investigating the combination of RAD001 (everolimus) with paclitaxel and carboplatin in first line treatment of patients with advanced Large Cell Lung Cancer with Neuroendocrine Differentiation (LCNEC) - a case report
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 88
  • Altorki, N. K.; O'brien, MER; Eberhardt, Wilfried; Richardson, F. C.; Wang, J.; Foley, M. A.; Horan, J. D.; Shepherd, F. A.; Kelly, K.;
    Adjuvant Erlotinib (E) Versus Placebo (P) for Completely Resected Stage IB-IIIA EGFR-Positive (IHC/FISH) Non-Small Cell Lung Cancer (NSCLC) : RADIANT Results: Locally Advanced Non-Small Cell Lung Cancer
    2014 Chicago Multidisciplinary Symposium in Thoracic Oncology ; 30 October-1 November 2014, Chicago, Illinois, USA,
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 90 (2014) Nr. 5, Supplement, S. S2 - S3
  • Niemeyer, D.; Engel-Riedel, W.; Brockmann, M.; Grohe, C.; Schumann, C.; Kollmeier, J.; von Pawel, J.; Eberhardt, Wilfried; Gutz, S.; Weiss, C.; Potzner, M.; Nimmrich, I.; Serke, M.; Thomas, M.;
    Case report from a patient with a histology shift from large cell neuroendocrine carcinoma of the lung (LCNEC) to small cell lung cancer (SCLC) after first line treatment in a trial investigating everolimus combined with paclitaxel and carboplatin
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 68 - 69
  • Köhler, Johannes; Schuler, Martin; Gauler, Thomas; Nopel-Dunnebacke, S.; Hoffmann, Andreas-Claudius; Kasper, Stefan; Nensa, Felix; Gomez, Benedikt; Hahnemann, M.; Breitenbücher, Frank; Cheufou, D.; Ozkan, F.; Darwiche, Kaid; Hoiczyk, M.; Welter, Stefan; Eberhardt, Wilfried; Teschler, Helmut; Stamatis, Georgios; Hahn, S. A.; Baraniskin, A.;
    Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 226 - 227
  • Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Friedel, G.; Veit, S.; Heinrich, V.; Welter, Stefan; Spengler, W.; Schmidberger, H.; Lutke-Brintrup, D.; Lehmann, Nils; Jöckel, Karl-Heinz; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried;
    Definitive Hyperfractionated Accelerated (AHF) Radiochemotherapy (CRT) Versus Neoadjuvant AHF-CRT and Surgery (S) for Patients (pts) With Operable Stage IIIA(N2)/Selected IIIB Non-small-Cell Lung Cancer (NSCLC) Following Induction Chemotherapy (IND-C) : Results From a Multicenter Phase III Study
    56th Annual Meeting of the American Society for Radiation Oncology ; 14-17 September 2014, San Francisco, CA, USA,
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 90 (2014) Nr. 1, Supplement, S. S146 - S147
  • Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Friedel, G.; Veit, S.; Heinrich, V.; Gkika, E.; Hepp, R.; Welter, Stefan; Spengler, W.; Schmidberger, H.; Lutke-Brintrup, D.; Lehmann, Nils; Jöckel, Karl-Heinz; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried;
    Definitive accelerated-hyperfractionated (AHF) Chemoradiotherapy (CRT) vs. neoadjuvant AHF-CRT and Surgery (S) for Patients with operable NSCLC in Stage IIIA(N2)/IIIB after Induction Chemotherapy (IND-C) : Results of a randomized Multicentre Study
    20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 190 (2014) Nr. Suppl. 1, S. 5 - 6
  • Schuette, W.; Eberhardt, Wilfried; von der Schulenburg, JMG; Dietel, M.; Schirmacher, P.; Zaun, S.; Zirrgiebel, U.; Thomas, M.
    Final Results from REASON, a Registry for the Epidemiologic and Scientific evaluation of EGFR mutation status in newly diagnosed NSCLC patients stage IIIB/IV in Germany
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 89
  • Stuschke, Martin; Abu Jawad, Jehad; Eberhardt, Wilfried; Grehl, Sara; Pöttgen, Christoph; Arnold, G.; Pfortner, R.; Gauler, Thomas; Schmeling, C.; Mohr, Christopher;
    Neoadjuvant Docetaxel/Cisplatin/5-FU based radiochemotherapy (RT-CT) increases pathologic complete remissions and survival of patients with locally advanced oral cavity carcinomas in comparison to RT-CT with cisplatin alone followed by resection – a long term observational study
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl.1, S. 79
  • Abu Jawad, Jehad; Pöttgen, Christoph; Gauler, Thomas; Eberhardt, Wilfried; Arnold, G.; Grehl, Sara; Pfortner, R.; Schmeling, C.; Mohr, Christopher; Stuschke, Martin;
    P6-9 Neoadjuvante Radiochemotherapie beim lokal fortgeschrittenen Mundhöhlenkarzinom : Vergleich der Langzeitergebnisse zweier Protokolle
    20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,
    In: Strahlentherapie und Onkologie Jg. 190 (2014) Nr. Suppl.1, S. 99 - 100
  • Pöttgen, Christoph; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Kleinhans, J.; Jendrossek, Verena; Freitag, Lutz; Abu Jawad, Jehad; Gkika, E.; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, M.; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin;
    Prognostisches Modell für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion
    20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 190 (2014) Nr. Suppl 1, S. 17
  • Nogova, L.; Gardizi, M.; Bos, M.; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L.; Schildhaus, H. U.; Fuhr, U.; Sos, M.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Thomas, R.; Buttner, R.; Wolf, J.;
    TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 92
  • Nogova, Lucia; Gardizi, Masyar; Bos, Marc Christiaan Allardt; Scheffler, Matthias; Mattonet, Christian; Heukamp, Lukas Carl; Schildhaus, Hans-Ulrich; Fuhr, Uwe; Eberhardt, Wilfried; Reis, Henning; Wiesweg, Marcel; Schmid, Kurt Werner; Schoch, Gernot; Ko, Yon-Dschun; Serke, Monika Heidi; Schuler, Martin H.; Büttner, Reinhard; Wolf, Jürgen
    TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, Suppl., S. 8109
  • Pöttgen, Christoph; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Freitag, Lutz; Abu Jawad, Jehad; Gkika, E.; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, M.; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin;
    Vergleich von pCR und mediastinalem Downstaging als Surrogat- Marker für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion (Trimodalität)
    20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 190 (2014) Nr. Suppl. 1, S. 17
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, K.; Kasper, Stefan; Bauer, Sebastian; Gauler, Thomas; Welt, Anja; Richly, Heike; Tewes, Mitra; Meiler, Johannes; Hense, Jörg; Eberhardt, Wilfried; Derks, Christian; Cortes-Incio, D.; Skottky, S.; Wohlschläger, Jeremias; Breitenbucher, F.; Freitag, Lutz; Stamatis, Georgios; Schmid, Kurt Werner; Schuler, Martin;
    WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 2 - 3
  • Schumann, C.; Engel-Riedel, W.; Kollmeier, J.; Grohe, C.; von Pawel, J.; Eberhardt, Wilfried; Gutz, S.; Nimmrich, I.; Weiss, C.; Potzner, M.; Serke, M.; Thomas, M.;
    A multi-centric, open-label, phase II study investigates the combination of RAD001 (everolimus) with paclitaxel and carboplatin in first line treatment of patients with advanced (stage IV) Large Cell Lung Cancer with Neuroendocrine Differentiation (LCNEC)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 252
  • Pöttgen, Christoph; Eberhardt, Wilfried; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Freitag, Lutz; Abu Jawad, Jehad; Wohlschläger, Jeremias; Welter, Stefan; Stamatis, Georgios; Stuschke, Martin;
    Akzeleriert-hyperfraktionierte Radiotherapie (RTx) mit simultaner Chemotherapie (CTx) im neoadjuvanten Konzept bei Stadium-III-Lungenkarzinom : signifikant höhere Rate pathologisch kompletter Remissionen (pCR) im Vergleich mit konventioneller Fraktionierung
    19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,
    In: Strahlentherapie und Onkologie Jg. 189 (2013) Nr. Suppl. 1, S. 19
  • Pöttgen, Christoph; Abu Jawad, Jehad; Gkika, E.; Berkovic, Katharina; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin;
    Akzelerierte Post-Pneumonektomie Salvage-Bestrahlung (RTx) mit simultaner Chemotherapie (CTx) bei Patienten mit kontralate - ralen zentralen Lungenkarzinomrezidiven
    DEGRO 2013 19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,
    In: Strahlentherapie und Onkologie Jg. 189 (2013) Nr. Suppl. 1, S. 67
  • Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Friedel, G.; Kohlhaufl, M.; Hehr, T.; Budach, W.; Bamberg, M.; Welter, Stefan; Stamatis, Georgios; Fischer, B.; Jöckel, Karl-Heinz; Eberhardt, Wilfried;
    Compliance-Analyse der prospektiv-randomisierten multizentrischen ESPATÜ-Studie – lassen sich Patienten lieber operieren?
    19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,
    In: Strahlentherapie und Onkologie Jg. 189 (2013) Nr. Suppl. 1, S. 87
  • Griesinger, F.; Falk, M.; Conradi, I.; Halbfass, V.; Reinhardt, M.; Kluge, A.; Willborn, K. C.; Prenzel, R.; Scriba, D.; Henke, R. P.; Eberhardt, Wilfried; Hallas, C.; Tiemann, M.;
    Pathologic complete remission after induction chemotherapy and intercalated Erlotinib in EGFR-mutated adenocarcinoma stage IIIA : Case report
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 253 - 254
  • Griesinger, F.; Falk, M.; Conradi, I.; Halbfass, V.; Reinhardt, M.; Kluge, A.; Willborn, K.; Prenzel, R.; Scriba, D.; Henke, R. P.; Eberhardt, Wilfried; Hallas, C.; Tiemann, M.;
    Pathologic complete remission after induction chemotherapy and intercalated erlotinib in EGFR-mutated adenocarcinoma stage IIIA : CASE REPORT
    15th World Conference on Lung Cancer, October 27 - 30 2013, Sydney, Australia,
    In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. Suppl. 2, S. S1169 - S1170
  • Nel, I.; Gauler, Thomas; Nickel, A.; Eberhardt, Wilfried; Thomale, Jürgen; Schuler, Martin; Hoffmann, A.;
    Prä-therapeutische ex-vivo Reparatur Kinetiken von Cisplatin-DNA-Addukten in Zirkulierenden Tumorzellen als Platin-Resistenz Test
    119. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., 06. - 09. April 2013, Wiesbaden,
    In: Der Internist Jg. 54 (2013) Nr. Suppl. 1, S. 95 - 96
  • Nogova, L.; Gardizi, M.; Bos, MCA; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L. C.; Schildhaus, H. U.; Fuhr, U.; Sos, M. L.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Thomas, R. K.; Buttner, R.; Wolf, J.
    TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 30
  • Mitchell, P. L.; Butts, C. A.; Socinski, M. A.; Thatcher, N.; Wickart-Johansson, G.; Ellis, P. M.; Gladkov, O.; Pereira, J. R.; Eberhardt, Wilfried; Horwood, K.; Szczesna, A.; Helwig, C.; Schroder, A.; Shepherd, F. A.;
    Tecemotide (L-BLP25) in unresectable stage III non-small cell lung cancer in the phase III start study : Further endpoint and exploratory biomarker results
    15th World Conference on Lung Cancer, October 27 - 30 2013, Sydney, Australia,
    In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. Suppl. 2, S. S135 - S136
  • Nogova, L.; Bos, M.; Gardizi, M.; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L. C.; Schildhaus, H.; Fuhr, U.; Sos, M. L.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Buttner, R.; Wolf, J.
    Try : a phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. Suppl. 2, S. S914 - S915
  • Abu Jawad, Jehad; Grehl, Sara; Pöttgen, Christoph; Pfoertner, R.; Eberhardt, Wilfried; Gauler, Thomas; Arnold, G.; Mohr, Christopher; Stuschke, Martin;
    Vergleich einer neoadjuvanten Radiochemotherapie mit Docetaxel/Cisplatin/5-FU oder mit Cisplatin alleine beim lokal fortgeschrittenen Mundhöhlenkarzinom
    19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,
    In: Strahlentherapie und Onkologie Jg. 189 (2013) Nr. Suppl. 1, S. 100
  • Theegarten, Dirk; Gauler, Thomas; Graupner, B.; Pöttgen, Christoph; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried; Freitag, Lutz; Welter, Stefan; Abu Jawad, Jehad;
    Accelerated Hyperfractionated Radiation Therapy Within Trimodality Therapy Concepts for Stage IIIa/b Non-small Cell Lung Cancer : Markedly Higher Rate of Pathologic Complete Remissions Than With Conventionally Fractionated Radiochemotherapy
    54th Annual Meeting of the American Society for Radiation Oncology ; 28-31 October 2012, Boston, MA, USA,
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 84 (2012) Nr. 3, Supplement, S. S154
  • Pöttgen, Christoph; Goer, S.; Koitsch, R.; Abu Jawad, Jehad; Gkika, E.; Berkovic, Katharina; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin
    Einfluss der Induktions-Chemotherapie auf die Parameter der hochdosierten Radiochemotherapie beim lokal fortgeschrittenen Lungenkarzinom
    In: Strahlentherapie und Onkologie Jg. 188 (2012) Nr. 1 Suppl., S. 96
  • Christoph, Daniel C.; Asuncion, Bernadette Reyna; Wynes, Murry; Gauler, Thomas C.; Wohlschläger, Jeremias; Theegarten, Dirk; Welter, Stefan; Tran, Cindy; Hassan, Biftu; Loewendick, Heike; Peglow, Anja; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Folylpoly-α-glutamate synthetase and thymidylate synthase are associated with clinical outcome from pemetrexed-based therapy in advanced non-small cell lung cancer (NSCLC)
    In: Cancer Research Jg. 72 (2012) Nr. 8, Suppl., S. 1713
  • Grehl, Sara; Eberhardt, Wilfried; Pöttgen, Christoph; Abu Jawad, Jehad; Kaelberlah, Hans-Peter; Gauler, Thomas; Arnold, G.; Mohr, Christopher; Stuschke, Martin
    Neoadjuvante Therapie beim lokal fortgeschrittenen Mundhöhlenkarzinom : Induktionschemotherapie mit Docetaxel/Cisplatin/5-FU gefolgt von simultaner Strahlentherapie plus Docetaxel/Cisplatin gefolgt von OP – Phase-I-Studie: Ergebnisse und 3J-FU
    In: Strahlentherapie und Onkologie Jg. 188 (2012) Nr. 1 Suppl., S. 90 - 90
  • Pöttgen, Christoph; Abu Jawad, Jehad; Gkika, E.; Berkovic, Katharina; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin;
    Postpneumonectomy Radical Accelerated (Re-)irradiation and Concurrent Chemotherapy for Patients With Contralateral Central Lung Cancer Relapses
    54th Annual Meeting of the American Society for Radiation Oncology ; 28-31 October 2012, Boston, USA,
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 84 (2012) Nr. 3, Supplement, S. S598
  • Schirmacher, P.; Eberhardt, Wilfried; Thomas, M.; Dietel, M.; Schütte, W.; Zirrgiebel, U.; Graf von der Schulenburg, J.M.; Gutendorf, B.
    Mutation Testing and First Line Treatment of Patients With Advanced NSCLC and Positive EGFR Mutation Status – Results From a German Registry
    In: European Journal of Cancer Jg. 47 (2011) Nr. Suppl. 1, S. S636
  • O'Byrne, K.; von Pawel, J.; Vynnychenko, I.; Eberhardt, Wilfried; De Marinis, F.; Paz-Ares, L.; Goddemeier, T.; Schumacher, K.; Gatzemeier, U.; Pirker, R.;
    1stCycle rash as a Clinical Marker of outcome in Patients with advanced Non-Small Cell Lung Cancer (NSCLC) receiving 1st-Line Chemotherapy (CT) plus Cetuximab : Analysis by Histology
    35th ESMO (European Society for Medical Oncology) Congress. Milan, Italy. October 8-12, 2010,
    In: Annals of Oncology Jg. 21 (2010) Nr. Suppl. 8, S. 131 - 132
  • Reck, M.; Stieglmaier, J.; Thomas, M.; Eberhardt, Wilfried; Engel-Riedel, W.; Waller, C.; Harbeck, N.; von Pawel, J.;
    ASA404 (a Tumor-VDA) in advanced solid tumors : an update on clinical trials
    29. Deutscher Krebskongress. Berlin 24.-27. Februar 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 2, S. 154 - 154
  • Bischof, H.; Serke, M.; Reck, M.; Eberhardt, Wilfried; Schutte, W.; Fischer, J.; von Pawel, J.; Eschbach, C.; Gutz, S.; Schumann, C.; Heinzmann-Groth, I.; Zaun, S.; Thomas, M.;
    Baseline population description of the German patient population in the EPICLIN-Lung epidemiological study in Non-Small Cell Lung Cancer (NSCLC) across Europe
    29. Deutscher Krebskongress. Berlin 24.-27. Februar 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 2, S. 129 - 130
  • Wynes, M. W.; Dziadziuszko, R.; Singh, S.; Christoph, Daniel; Ranger-Moore, J.; Szostakiewicz, B.; Dziadziuszko, K.; Eberhardt, Wilfried; Jassem, J.; Hirsch, F. R.
    Increased Thymidylate Synthase (TS) Gene Copy Number in NSCLC
    In: Journal of Thoracic Oncology Jg. 5 (2010) Nr. 5 Suppl. 1, S. S56
  • Eberhardt, Wilfried; Gauler, Thomas; W German Tumour Ctr;
    Neoadjuvant therapy in stage III
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 7, S. 102 - 103
  • Gauler, Thomas; Eberhardt, Wilfried;
    Peritoneal mesothelioma
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 12 - 13
  • Griesinger, F.; Bearz, A.; Eberhardt, Wilfried; Garrido, P.; Isla, D.; Ko, Y.; Kohlhaeufl, M.; Schneider, C.; Thatcher, N.; Pavlakis, N.;
    Safety of First-Line Bevacizumab (BV)-Based Therapy in the Sail (MO19390) Trail : Central Tumour Locazion (CTL) and Hypertension (HTN) in Patients (PTS) with advanced Non-Small Cell Lung Cancer (NSCLC)
    35th ESMO Congress, Milan, Italy 8–12 October 2010,
    In: Annals of Oncology Jg. 21 (2010) Nr. Suppl. 8, S. 144
  • Schutt, P.; Eberhardt, Wilfried;
    Targeted therapy for patients with thyroid cancer
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 214
  • Gottschling, S.; Herpel, E.; Eberhardt, Wilfried; Gatzemeier, U.; Fischer, J. R.; Kohne, C. H.; Kortsik, C.; Kuhnt, T.; Muley, T.; Meister, M.; von Romer, K. S.; Bischoff, H.; Schnabel, P. A.; Penzel, R.; Thomas, M.;
    The gefitinib Long-Term Survivor (LTS) - a species on its own? : Molecular and clinico-pathological characteristics of German Long-Term Survivors treated in the Iressa Expanded Access Program (EAP)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 1.–5. Oktober 2010, Berlin,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 103 - 103
  • Beiträge in Sammelwerken und Tagungsbänden

  • Eberhardt, Wilfried; Van Schil, Paul E.; Curran, Walter; Socinski, Mark A.
    Stage iiib non-small cell lung cancer
    In: Principles and Practice of Lung Cancer: The Official Reference Text of the International Association for the Study of Lung Cancer (IASLC) / Pass, Harvey I. (Hrsg.) 2012, S. 821 - 836